👪

Inheritance

2

Autosomal dominant (nonclassic WFS1-SD) HP:0000006

A single heterozygous WFS1 variant is sufficient. It may be transmitted from an affected parent or arise de novo; for the recurrent p.A684V allele de novo occurrence is the rule rather than the exception, confirmed in seven of thirteen families in the largest series. Dominance here is a statement about the allele, not only about the pedigree. Carriers of truncating WFS1 alleles - the obligate heterozygotes in recessive Wolfram families - generally hear normally, so halving wolframin dose does not cause the disease. The dominant alleles are missense changes and small in-frame deletions in exon 8.

Autosomal dominant inheritance

Show evidence (3 references)

PMID:20301750 SUPPORT Human Clinical

"Nonclassic WFS1-SD is caused by a heterozygous pathogenic variant and can either be inherited in an autosomal dominant manner from an affected parent or result from a de novo WFS1 pathogenic variant."

States the mode of inheritance and both routes to a heterozygous variant.

PMID:36833385 SUPPORT Human Clinical

"Heterozygous carriers of truncating variants generally do not have HL; a heterozygous inactivating variant thus does not lead to a phenotype."

The argument that dominance here cannot be haploinsufficiency, which is what makes the allele type, rather than allele dose alone, the discriminator.

PMID:39858604 SUPPORT Human Clinical

"Among the 14 patients from 13 families with the p.A684V variant, nine were sporadic cases. In addition, we confirmed de novo occurrence of this variant in seven families."

Quantifies how often the commonest dominant allele arises de novo, which is why a negative family history does not argue against this diagnosis.

Autosomal recessive (classic WFS1-SD) HP:0000007

The classic arm needs two inactivating WFS1 alleles. It is recorded here for completeness of the allelic series; the recessive disease itself is curated in the Wolfram_Syndrome entry.

Autosomal recessive inheritance

Show evidence (1 reference)

PMID:20301750 SUPPORT Human Clinical

"Classic WFS1-SD is caused by biallelic WFS1 pathogenic variants and is inherited in an autosomal recessive manner."

The inheritance statement for the classic arm.

◆

Subtypes

4

Classic WFS1 spectrum disorder (biallelic, DIDMOAD) MONDO:0009101

WFS1 hgnc:12762

The recessive arm: biallelic inactivating WFS1 variants producing childhood-onset insulin-dependent diabetes mellitus and optic atrophy, then high-frequency sensorineural hearing loss, central diabetes insipidus, neurogenic bladder, and brainstem neurodegeneration. It is listed here because it is part of the same MONDO concept and the same allelic series, but its mechanism, natural history, treatments and trials are curated in full in the separate Wolfram_Syndrome entry, which covers the CISD2-related form as well. Everything below in this entry is about the dominant arm unless it says otherwise.

Show evidence (1 reference)

PMID:20301750 SUPPORT Human Clinical

"Classic WFS1-SD is caused by biallelic WFS1 pathogenic variants and is inherited in an autosomal recessive manner."

Defines the classic arm by allele dose and inheritance, which is what separates it from the rest of the series.

DFNA6/14/38 low-frequency nonsyndromic sensorineural hearing loss MONDO:0010963

WFS1 hgnc:12762

Isolated, dominantly inherited low-frequency sensorineural hearing loss at 2 kHz and below, with no optic atrophy, diabetes or other syndromic feature. Three separate deafness loci - DFNA6, DFNA14 and DFNA38 - turned out to be the same gene. Onset ranges from congenital to the fifth decade and the loss worsens over time without reaching profound deafness. This is the most common form of hereditary low-frequency hearing loss.

Show evidence (2 references)

PMID:11709537 SUPPORT Human Clinical

"Herein we report five different heterozygous missense mutations (T699M, A716T, V779M, L829P, G831D) in the WFS1 gene found in six LFSNHL families."

The founding observation that heterozygous WFS1 missense alleles cause isolated low-frequency hearing loss.

PMID:36833385 SUPPORT BACKGROUND Human Clinical

"The DFNA6, DFNA14 and DFNA38 loci were initially reported separately but were later found to be associated with pathogenic variants in the same gene: WFS1"

Why the subtype carries three locus names. BACKGROUND because this paper restates the earlier mapping work rather than reporting it.

Wolfram-like syndrome (autosomal dominant) MONDO:0013673

WFS1 hgnc:12762

Dominantly inherited sensorineural hearing loss with optic atrophy and, variably, diabetes mellitus - the classic triad in attenuated, incomplete and often later-onset form. The recurrent allele p.A684V accounts for a large share of reported families, and p.E864K is the allele whose cellular phenotype has been taken apart in most detail.

Show evidence (4 references)

PMID:41048689 SUPPORT Human Clinical

"Wolfram-like syndrome is an autosomal dominant disorder related to classical autosomal recessive Wolfram syndrome. It is characterized by diabetes mellitus, optic atrophy, and sensorineural hearing loss, but typically presents with milder or incomplete features."

Defines the subtype and its relationship to the recessive disease.

PMID:21538838 SUPPORT Human Clinical

"Among these families, we found three heterozygous missense mutations in WFS1 segregating with OA and SNHL: p.A684V (six families), and two novel mutations, p.G780S and p.D797Y, all involving evolutionarily conserved amino acids and absent from 298 control chromosomes."

Establishes dominant optic atrophy plus hearing loss as a WFS1 phenotype and names the recurrent allele.

PMID:20301750 SUPPORT Human Clinical

"Phenotypes that appear to be milder than classic WFS1-SD include: optic atrophy and hearing impairment"

The reference chapter listing this combination among the nonclassic phenotypes, which is what places the subtype inside WFS1-SD rather than beside it.

+ 1 more reference

WFS1 neonatal/infancy-onset diabetes with congenital deafness and cataracts MONDO:0100072

WFS1 hgnc:12762

The most severe dominant presentation and the one that is usually de novo: diabetes diagnosed before twelve months, sensorineural deafness found soon after birth, congenital cataracts and hypotonia. The alleles behind it behave differently in vitro from recessive Wolfram alleles - they aggregate and induce robust endoplasmic reticulum stress rather than simply failing - which is why the reporting group called it a discrete pathophysiology rather than severe Wolfram syndrome.

Show evidence (1 reference)

PMID:28468959 SUPPORT Human Clinical

"They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."

The defining feature set of this subtype, with its per-feature counts.

?

Discussions and Knowledge Gaps

2

Why does the non-syndromic dominant form of WFS1 disease take the low frequencies while the syndromic forms take the high ones, when wolframin is expressed without a basal-to-apical gradient along the cochlea?

KNOWLEDGE GAP wfs1_lfsnhl_frequency_specificity

Attached to

pathophysiology#Impaired Inner Ear Ion Homeostasis phenotypes#Low-frequency sensorineural hearing loss

This is the central unexplained fact of the entry and it constrains the mechanism. A frequency-specific audiometric phenotype normally invites a gradient explanation - more protein, or more dependence on it, at one end of the cochlea than the other. The one localisation study that looked found no such gradient. So either the relevant quantity is not expression level, or the lesion acts on something that varies along the cochlea for another reason. Until this is settled, the Impaired Inner Ear Ion Homeostasis node in this entry cannot account for the phenotype it points at, which is why it is marked HYPOTHETICAL.

Show evidence (2 references)

PMID:36833385 SUPPORT Human Clinical

"It is not yet understood why some variants lead to syndromic and others to non-syndromic disease or why DFNA6/14/38 is characterized by LFSNHL, while in most syndromic forms, the higher frequencies are typically affected."

The field's own statement of the gap, covering both halves of it.

PMID:12649740 SUPPORT Model Organism

"Although there were observable developmental differences, no differences in staining pattern or gradients of expression were observed between the basal and apical parts of the cochlea."

The negative result that rules out the obvious explanation, in mouse inner ear.

Do the dominant WFS1 alleles act by interfering with wild-type wolframin, or by a toxic gain of function, and does the answer differ between the mild non-syndromic alleles and the aggregating de novo ones?

KNOWLEDGE GAP wfs1_dominant_allele_mechanism

Attached to

pathophysiology#Mutant Wolframin Interference with Wild-Type Wolframin pathophysiology#Heterozygous Non-Inactivating WFS1 Variant in Exon 8

The two readings are offered side by side in the literature and have never been separated experimentally for the non-syndromic alleles. They are not interchangeable: dominant-negative interference predicts that the phenotype depends on the wild-type allele being present and on the two proteins meeting, while toxic gain of function predicts a cell-autonomous burden that antisense knockdown of the mutant allele would relieve regardless. The aggregating alleles of the neonatal-diabetes subtype do have a measured gain-of-function-like behaviour, which is the one point in the series where the question has an answer - and it is an answer for one allele class only.

Show evidence (3 references)

PMID:36833385 SUPPORT Human Clinical

"are non-inactivating variants with a dominant-negative effect in which the mutant protein impairs the function of the wild-type protein"

The dominant-negative reading, which is one of the two candidates this discussion is about.

PMID:36833385 SUPPORT Human Clinical

"Alternatively, the aberrant protein has a toxic gain-of-function effect."

The other candidate, from the sentence immediately after the one above. The two are quoted separately because a bracketed reference marker between them is stripped by the snippet validator.

PMID:28468959 SUPPORT In Vitro

"In vitro studies showed that these WFS1 mutations are functionally different from the known recessive Wolfram syndrome-causing mutations, as they tend to aggregate and induce robust endoplasmic reticulum stress."

The one allele class where the question has been addressed experimentally, and the answer does not transfer to the mild non-syndromic alleles.

⚙

Pathophysiology

10

Heterozygous Non-Inactivating WFS1 Variant in Exon 8

Mechanism confidence: Established

The initiating lesion of the dominant arm. Every variant unambiguously associated with dominant WFS1 disease, syndromic or not, is a missense change or a small in-frame deletion in exon 8, the last and largest exon, which encodes the transmembrane and C-terminal domains of wolframin. Truncating alleles in the heterozygous state do not cause the disease, so this is not a dose lesion: the mutant protein has to be made for the phenotype to appear.

WFS1 hgnc:12762

Genetic context variant_origin: GERMLINE functional_impact_category: UNKNOWN

variant_origin is GERMLINE rather than DE_NOVO because the node covers both routes: transmitted from an affected parent, and arising de novo, which is the rule for p.A684V and for the alleles behind the neonatal-diabetes subtype. GERMLINE is the superset and asserts only what is true of every allele in the node. functional_impact_category is UNKNOWN rather than DOMINANT_NEGATIVE because the literature offers two competing readings and settles neither. The group that states the argument most explicitly proposes dominant-negative interference with the wild-type protein and then names a toxic gain of function as the alternative in the same paragraph. Recording either value would assert a resolution nobody has reached; the two candidate mechanisms are modelled as separate downstream nodes instead.

Downstream

Mutant Wolframin Interference with Wild-Type Wolframin The dominant-negative reading, argued from the absence of a phenotype in truncating heterozygotes rather than demonstrated biochemically.

Mutant Wolframin Aggregation and Endoplasmic Reticulum Stress The measured route for the de novo alleles causing neonatal diabetes with congenital deafness and cataracts.

Reduced Steady-State Wolframin Level A third route, measured for the recurrent p.A684V allele: the mutant protein is present at lower levels than wild type when expressed in cells.

Show evidence (1 reference)

PMID:36833385 SUPPORT Human Clinical

"All variants indisputably associated with autosomal dominantly inherited disease, both syndromic (Wolfram-like syndrome) and non-syndromic (DFNA6/14/38), are missense variants or small in-frame deletions located in exon 8."

Locates the dominant alleles in the gene and states their type, which is the content of this node.

Mutant Wolframin Interference with Wild-Type Wolframin

Mechanism confidence: Hypothetical

The proposed dominant-negative step: mutant wolframin, made and retained rather than degraded, impairs the function of the wild-type protein it is co-expressed with. This node is deliberately marked HYPOTHETICAL. No published experiment in this literature demonstrates the interaction; it is an inference from the fact that losing one allele outright causes nothing while making one abnormal protein causes disease.

Downstream

Loss of Endoplasmic Reticulum Calcium Homeostasis and MAM Integrity

Show evidence (1 reference)

PMID:36833385 SUPPORT INDIRECT Human Clinical

"Heterozygous carriers of truncating variants generally do not have HL; a heterozygous inactivating variant thus does not lead to a phenotype."

The observation the hypothesis rests on. INDIRECT because it is a negative clinical observation about a different allele class, not a measurement of interference.

Mutant Wolframin Aggregation and Endoplasmic Reticulum Stress

Mechanism confidence: Established

The de novo alleles behind neonatal diabetes with congenital deafness and cataracts aggregate and drive a strong unfolded protein response, which is the opposite of what a simple null does. This is the node that makes the severe dominant presentation a different mechanism rather than a worse version of the recessive one.

endoplasmic reticulum unfolded protein response GO:0030968 ↑ INCREASED response to endoplasmic reticulum stress GO:0034976 ↑ INCREASED

endoplasmic reticulum membrane GO:0005789

Downstream

Pancreatic Beta-Cell Failure

Lens Fibre Opacification

Profound congenital deafness

Show evidence (2 references)

PMID:28468959 SUPPORT In Vitro

"In vitro studies showed that these WFS1 mutations are functionally different from the known recessive Wolfram syndrome-causing mutations, as they tend to aggregate and induce robust endoplasmic reticulum stress."

The experimental statement of this node.

PMID:28468959 SUPPORT Human Clinical

"This syndrome has a discrete pathophysiology and differs genetically and clinically from recessive Wolfram syndrome."

The authors' own reading of what that difference means for nosology, which is why this subtype is not folded into classic disease.

Reduced Steady-State Wolframin Level

Mechanism confidence: Provisional

Ectopically expressed p.A684V wolframin is present at lower levels than wild type. How this squares with dominance is not resolved in the reporting paper: a lower level of a mutant protein is not by itself an explanation for why one abnormal allele is worse than one absent allele.

Downstream

Loss of Endoplasmic Reticulum Calcium Homeostasis and MAM Integrity

Show evidence (1 reference)

PMID:21538838 SUPPORT In Vitro

"wolframin p.A684V mutant ectopically expressed in HEK cells showed reduced protein levels compared to wild-type wolframin, strongly indicating that the mutation is disease-causing."

The single measurement this node records.

Loss of Endoplasmic Reticulum Calcium Homeostasis and MAM Integrity

Mechanism confidence: Established

Wolframin is a resident of the mitochondria-associated endoplasmic reticulum membrane, the contact site across which calcium moves from the endoplasmic reticulum to the mitochondrion. The Wolfram-like allele p.E864K reduces mitochondrial calcium uptake and bioenergetics in human fibroblasts and mouse neurons, and the knock-in mouse has fewer contact sites. This is the node at which the dominant and recessive arms converge: the same compartment fails, reached by a different route.

endoplasmic reticulum calcium ion homeostasis GO:0032469 ↓ DECREASED

mitochondria-associated endoplasmic reticulum membrane GO:0044233

Downstream

Mitochondrial Dysfunction with Deregulated Autophagy and Mitophagy

Impaired Inner Ear Ion Homeostasis Proposed rather than demonstrated: wolframin sits in the endoplasmic reticulum of inner ear cells in a pattern matching the canalicular reticulum, the specialisation implicated in transcellular ion movement.

Retinal Ganglion Cell and Optic Nerve Degeneration

Pancreatic Beta-Cell Failure

Show evidence (2 references)

PMID:38651637 SUPPORT Model Organism

"Moreover, in the Wfs1E864K mouse, these alterations are concomitant with a decrease of MAM number."

The structural counterpart of the functional defect, measured in the knock-in animal carrying a human Wolfram-like allele.

PMID:38651637 SUPPORT In Vitro

"These findings reveal pathophysiological similarities between WS and WLS, highlighting the importance of WFS1 for MAM's integrity and functionality."

States the convergence between the dominant and recessive arms at this compartment, which is the reason this node is shared rather than split.

Mitochondrial Dysfunction with Deregulated Autophagy and Mitophagy

Mechanism confidence: Established

Downstream of the contact-site defect: reduced mitochondrial bioenergetics, a deregulated mitochondrial quality-control system, and altered autophagic flux, shown for p.E864K in human fibroblasts, mouse neurons and the knock-in mouse.

autophagy GO:0006914 ↕ DYSREGULATED mitophagy GO:0000423 ↕ DYSREGULATED

Downstream

Retinal Ganglion Cell and Optic Nerve Degeneration

Show evidence (1 reference)

PMID:38651637 SUPPORT In Vitro

"Here, we show that in human fibroblasts and murine neuronal cultures the WLS protein WFS1E864K leads to decreases in mitochondria bioenergetics and Ca2+ uptake, deregulation of the mitochondrial quality system mechanisms, and alteration of the autophagic flux."

The measurements this node records, in two cell systems.

Impaired Inner Ear Ion Homeostasis

Mechanism confidence: Hypothetical

The step between the cellular defect and the audiogram, and the weakest link in the chain. Wolframin is present in the endoplasmic reticulum of many inner ear cell types, in a distribution resembling the canalicular reticulum that is thought to handle transcellular ion movement, so an ion-homeostasis failure is the natural candidate. It has not been measured in a WFS1 ear. Crucially, expression shows no basal-to-apical gradient along the cochlea, so this node as stated does not explain why the non-syndromic form takes the low frequencies and the syndromic forms take the high ones.

internal ear UBERON:0001846 cochlea UBERON:0001844

Downstream

Low-frequency sensorineural hearing loss

Progressive sensorineural hearing impairment

Congenital severe-to-profound sensorineural hearing impairment

Tinnitus

Show evidence (2 references)

PMID:12649740 SUPPORT Model Organism

"Double immunostaining with an endoplasmic reticulum marker confirmed that wolframin localizes to this organelle."

Places the protein in the compartment this node is about, in the inner ear.

PMID:12649740 SUPPORT Model Organism

"Although there were observable developmental differences, no differences in staining pattern or gradients of expression were observed between the basal and apical parts of the cochlea."

The negative result that keeps this node from explaining the audiogram shape: there is no expression gradient to map onto a frequency gradient.

Pancreatic Beta-Cell Failure

Mechanism confidence: Provisional

Insulin-secreting beta cells are among the cells that depend most on wolframin, and in the dominant arm their failure ranges from neonatal insulin-requiring diabetes with the aggregating alleles to adult-onset diabetes in Wolfram-like syndrome. The step from the cellular defect to beta-cell loss is inferred from the clinical phenotype and from the recessive disease; no dominant-allele beta-cell experiment is cited here.

pancreatic beta cell CL:0000169

glucose homeostasis GO:0042593 ↓ DECREASED

Downstream

Neonatal insulin-dependent diabetes mellitus

Diabetes mellitus

Show evidence (1 reference)

PMID:28468959 SUPPORT Human Clinical

"Our results establish specific dominant WFS1 mutations as a cause of a novel syndrome including neonatal/infancy-onset diabetes, congenital cataracts, and sensorineural deafness."

Establishes that dominant WFS1 alleles cause insulin-requiring diabetes in the first year of life, which is the clinical read-out of this node at its most severe.

Retinal Ganglion Cell and Optic Nerve Degeneration

Mechanism confidence: Provisional

Optic atrophy in the dominant arm is retinal nerve fibre layer loss, and in the largest ophthalmic series it is accompanied by a finding not seen in recessive disease: a linear splitting of the outer plexiform layer on macular optical coherence tomography. Several patients in that series were asymptomatic, so this node can be present before the patient notices anything.

retinal ganglion cell CL:0000740

Downstream

Optic atrophy

Show evidence (2 references)

PMID:39552476 SUPPORT Human Clinical

"OCT demonstrated marked nerve fiber layer loss in all patients."

The structural measurement behind this node in the reported cohort.

PMID:39552476 SUPPORT Human Clinical

"In dominant disease, macular OCT demonstrated a linear splitting abnormality of the outer plexiform layer (OPL) not found in recessive disease."

A retinal finding specific to the dominant arm, which is the one place in this entry where the two arms differ structurally rather than only clinically.

Lens Fibre Opacification

Mechanism confidence: Hypothetical

Congenital cataract in the aggregating-allele subtype. The lens is included because the phenotype is consistent across the reported patients, not because a lens experiment exists; no cited work measures wolframin handling in lens fibre cells.

lens fiber cell CL:0011004

Downstream

Congenital cataract

Show evidence (1 reference)

PMID:28468959 SUPPORT Human Clinical

"They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."

The clinical observation of lens involvement, with its denominator.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

10

Ear 5

Low-frequency sensorineural hearing loss OBLIGATE Low-frequency hearing loss HP:0008542

Show evidence (4 references)

PMID:11709537 SUPPORT Human Clinical

"Non-syndromic low frequency sensorineural hearing loss (LFSNHL) affecting only 2000 Hz and below is an unusual type of hearing loss that worsens over time without progressing to profound deafness."

Defines the audiometric shape and the natural history of this phenotype.

PMID:36833385 SUPPORT Human Clinical

"At all ages, an LFSNHL (0.25-2 kHz) of about 50-60 decibel hearing level (dB HL) was observed."

The measured severity and frequency range in a large recently studied family.

PMID:37121227 SUPPORT REVIEW SYNTHESIS Human Clinical

"LFNSHL is most commonly caused by pathogenic variants in the WFS1 gene, but it is also important to consider changes in other HL genes, which may result in similar audiological phenotype."

Places WFS1 as the leading cause of this audiometric phenotype, and names the caveat that the audiogram alone does not make the diagnosis. REVIEW_SYNTHESIS because this is a narrative review's summary rather than its own cohort.

+ 1 more reference

Progressive sensorineural hearing impairment VERY_FREQUENT HP:0000408

Course: PROGRESSIVE

Show evidence (3 references)

PMID:11709538 SUPPORT Human Clinical

"Dominantly inherited progressive hearing loss DFNA38 is caused by heterozygosity for a novel mutation in WFS1, the gene for recessively inherited Wolfram syndrome."

States progression as part of the definition of the DFNA38 phenotype.

PMID:36833385 SUPPORT Human Clinical

"The self-reported age of onset of hearing loss (HL) ranged from congenital to 50 years of age."

The range of onset ages within a single family carrying one allele.

PMID:36833385 SUPPORT Human Clinical

"We would like to emphasize that conventional neonatal hearing screening programs are not sensitive to HL in DFNA6/14/38 patients, because high-frequency hearing thresholds are initially preserved."

The screening consequence, which is the clinically actionable part of this phenotype.

Congenital severe-to-profound sensorineural hearing impairment Congenital sensorineural hearing impairment HP:0008527

Deliberately not scoped to a subtype, and deliberately carrying no frequency. The allele spans the subtype boundary: it is the commonest allele in the series that defined Wolfram-like dominant optic atrophy with hearing loss, while in the fourteen-patient audiological series most carriers had hearing loss and nothing else - optic atrophy in two of eleven assessed, diabetes in none. Recording it under Wolfram-like syndrome would assert a syndromic presentation most of those patients did not have. A frequency would need a denominator across the whole entity, and the only denominators published are per-allele.

Show evidence (2 references)

PMID:39858604 SUPPORT Human Clinical

"The identified heterozygous p.A684V variant appears to be a hotspot mutation and likely to cause severe-to-profound hearing loss in early childhood."

The conclusion of the largest series assembled for this allele.

PMID:39858604 SUPPORT BACKGROUND Human Clinical

"In DFNA6/14/38 cases, hearing loss primarily affects low frequencies and progresses slowly without reaching a severe-to-profound range"

The contrast that makes this a distinct phenotype rather than the same one more severely expressed. BACKGROUND because the sentence restates the established DFNA6 picture rather than reporting this study's own patients.

Profound congenital deafness OBLIGATE Profound sensorineural hearing impairment HP:0011476

Show evidence (2 references)

PMID:28468959 SUPPORT Human Clinical

"They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."

Deafness in all five patients of the series that defined this subtype, with the timing that makes it congenital.

PMID:20301750 SUPPORT Human Clinical

"neonatal diabetes, profound congenital deafness, and cataracts"

The GeneReviews description of this nonclassic presentation, which is where the severity grading of the hearing loss comes from.

Tinnitus OCCASIONAL HP:0000360

Show evidence (1 reference)

PMID:11709537 SUPPORT Human Clinical

"This type of LFSNHL may be associated with mild tinnitus but is not associated with vertigo."

Records both the phenotype and the negative that differentiates it from the commonest mimic.

Endocrine 2

Diabetes mellitus FREQUENT HP:0000819

Show evidence (3 references)

PMID:39552476 SUPPORT Human Clinical

"Diabetes mellitus was present in five patients (detected after screening in one), sensorineural hearing loss in five and diabetes insipidus in one."

The frequency of diabetes in a dominant-weighted WFS1 series, and the fact that recognising the eye disease found it.

PMID:41048689 SUPPORT Human Clinical

"He had a known history of diabetes mellitus, diagnosed 2 years prior, managed with metformin 850 mg, half a tablet every 12 hours."

A worked instance of how late and how mild the diabetes of the dominant arm can be - non-insulin-requiring at diagnosis in a man in his fifties.

PMID:36764396 SUPPORT Human Clinical

"Diabetes mellitus was seen in 44% of the patients."

The pooled frequency of diabetes in Wolfram-like syndrome, which is markedly lower than in classic disease where it is a defining feature.

Neonatal insulin-dependent diabetes mellitus OBLIGATE HP:0000857

Show evidence (1 reference)

PMID:28468959 SUPPORT Human Clinical

"They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."

Age at diagnosis and completeness of penetrance within the reported series.

Eye 2

Optic atrophy VERY_FREQUENT HP:0000648

Show evidence (3 references)

PMID:39552476 SUPPORT Human Clinical

"Eight patients (six female, two male) from six families were diagnosed with optic atrophy at a mean age of 15.5 ± 6.2 years (range 8-23) with mean follow-up of 3.2 ± 3.4 years (range 1.5-12.1). Three were asymptomatic."

Age at diagnosis and the proportion presenting without symptoms, which is why this phenotype is found by screening rather than by complaint.

PMID:21538838 SUPPORT Human Clinical

"Our data support OA and SNHL as a phenotype caused by dominant mutations in WFS1 in these additional eight families."

Establishes optic atrophy with hearing loss as a dominant WFS1 phenotype.

PMID:36764396 SUPPORT Human Clinical

"The most common phenotype consisted of the combination of optic atrophy (87%) and hearing impairment (94%)."

The pooled frequency across 86 reported Wolfram-like patients, which is what frequency VERY_FREQUENT records here.

Congenital cataract VERY_FREQUENT Developmental cataract HP:0000519

Show evidence (1 reference)

PMID:28468959 SUPPORT Human Clinical

"They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."

The count of affected patients within the defining series.

Musculoskeletal 1

Hypotonia VERY_FREQUENT HP:0001252

Show evidence (1 reference)

PMID:28468959 SUPPORT Human Clinical

"They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."

The observation and its denominator.

🧬

Genetic Associations

1

WFS1

Gene: WFS1 hgnc:12762 relationship_type: CAUSATIVE

Show evidence (4 references)

PMID:36833385 SUPPORT Human Clinical

"All variants indisputably associated with autosomal dominantly inherited disease, both syndromic (Wolfram-like syndrome) and non-syndromic (DFNA6/14/38), are missense variants or small in-frame deletions located in exon 8. This is the last and largest exon of WFS1 and codes for the transmembrane..."

Locates the dominant allele class in the gene and says what that part of the gene encodes.

PMID:36833385 SUPPORT BACKGROUND Human Clinical

"Over 40 variants within this gene are known to cause LFSNHL [7]."

The size of the allelic series behind the non-syndromic phenotype. BACKGROUND because the count is cited from a variant database rather than produced here.

PMID:21538838 SUPPORT BACKGROUND Human Clinical

"In the dominantly inherited disease, LFSNHL, the WFS1 mutations are mainly missense mutations in exon 8; 28 different missense mutations have been identified"

The earlier count of the same allele series, quoted beside the later one rather than reconciled with it. BACKGROUND because it is this paper's framing of prior work.

+ 1 more reference

💊

Medical Actions

4

Cochlear implantation

Action: cochlear device implantation Ontology label: Surgical Procedure NCIT:C15329

Platform: Device

For the severe-to-profound congenital hearing loss of the p.A684V allele, cochlear implantation is the recommended intervention. In the series reporting that allele, the four implanted patients reached a mean aided level of 28.7 dB while the five using hearing aids reached 40.9 dB, and the authors note that amplification was insufficient in some. This does not generalise to DFNA6/14/38, where the loss is mild-to-moderate and low-frequency and speech perception typically stays good.

Mechanism Target:

Congenital severe-to-profound sensorineural hearing impairment — The implant bypasses the failing cochlea rather than correcting the wolframin defect, so it addresses the phenotype and leaves every other node untouched.

Show evidence (2 references)

PMID:39858604 SUPPORT Human Clinical

"Cochlear implantation is considered favorable in cases of hearing impairment due to this variant."

The recommendation, made specifically for the severe dominant allele.

PMID:39858604 SUPPORT Human Clinical

"The other four patients received bilateral cochlear implantation, and their hearing levels were improved to 28.7 dB on average (ranging from 22.5 dB to 33.4 dB)."

The outcome behind the recommendation, with its sample size visible.

Multidisciplinary supportive care

Action: Supportive Care NCIT:C15747

Platform: Other

There is no cure and no disease-modifying therapy for any part of the WFS1 spectrum. Management is supportive and distributed across specialties according to which manifestations a given patient has - diabetes care, ophthalmology and low vision, audiology and speech-language therapy, neurology, psychiatry, urology and medical genetics - with regular monitoring for manifestations that have not yet appeared.

Show evidence (2 references)

PMID:20301750 SUPPORT Human Clinical

"There is no cure for WFS1-SD."

The statement that sets the ceiling on everything in this section.

PMID:20301750 SUPPORT Human Clinical

"Surveillance: For both classic and nonclassic WFS1-SD, regular monitoring of existing manifestations, the response of an individual to supportive care, and the emergence of new manifestations is recommended."

The surveillance recommendation, stated for the dominant arm explicitly and not only for classic disease.

Preconception and pregnancy glycaemic management

Action: Supportive Care NCIT:C15747

Platform: Other

Insulin-dependent diabetes is a feature of the dominant arm as well as the recessive one, so a pregnant patient carries the raised risk of diabetic embryopathy that goes with it - two- to eightfold, by the reference chapter's figure. Optimising glucose control before and during pregnancy reduces that risk without abolishing it. The diabetes-insipidus monitoring that GeneReviews adds for pregnancy applies to classic disease, so it is not carried here.

Show evidence (2 references)

PMID:20301750 SUPPORT Human Clinical

"Pregnant women with insulin-dependent diabetes mellitus, a characteristic of both classic and nonclassic WFS1-SD, have a two- to eightfold higher risk of having a child with a birth defect or a pattern of birth defects (diabetic embryopathy) than women who do not have diabetes."

The risk figure and, in the same sentence, the statement that it applies to the nonclassic arm and not only to classic disease.

PMID:20301750 SUPPORT Human Clinical

"Optimizing glucose control before and during pregnancy can reduce"

The intervention, and the limit the chapter puts on it in the same sentence.

Genetic counseling and testing of at-risk relatives

Action: Genetic Counseling NCIT:C15240

Platform: Other

Counseling for the dominant arm differs from the recessive arm at every point: a 50% risk to offspring of an affected parent rather than a 25% risk to sibs, and a de novo-heavy allele spectrum in which an unaffected-parent pedigree is common. Testing at-risk relatives is recommended so that diabetes mellitus, optic atrophy and hearing loss can be treated as early as possible - which, given how often optic atrophy is asymptomatic at diagnosis, is a real yield rather than a formality.

Show evidence (2 references)

PMID:20301750 SUPPORT Human Clinical

"If a parent of the proband is affected and/or is known to have the pathogenic variant identified in the proband, the risk to sibs of inheriting the pathogenic variant is 50%."

The recurrence risk specific to the dominant arm.

PMID:20301750 SUPPORT Human Clinical

"It is appropriate to clarify the genetic status of apparently asymptomatic at-risk relatives in order to identify as early as possible those who would benefit from prompt initiation of treatment for the earliest manifestations of WFS1-SD: diabetes mellitus, optic atrophy, and sensorineural hearing loss."

The cascade-testing recommendation and the manifestations it is aimed at.

🔬

Diagnosis

3

Molecular genetic testing for a heterozygous WFS1 variant

The diagnosis of nonclassic WFS1-SD is made by finding one pathogenic or likely pathogenic WFS1 variant in a proband with suggestive findings. Allele dose is what separates the two arms diagnostically, not the phenotype: the same gene with two inactivating alleles gives classic disease. Because the commonest dominant allele is usually de novo, an absent family history does not argue against the diagnosis, and in the largest series most probands were sporadic.

Show evidence (1 reference)

PMID:20301750 SUPPORT Human Clinical

"Nonclassic WFS1-SD. The diagnosis is established in a proband with suggestive findings and a heterozygous pathogenic (or likely pathogenic) variant identified by molecular genetic testing."

The diagnostic criterion for the dominant arm, stated by the reference source.

Frequency-specific audiometry rather than newborn hearing screening

Standard newborn hearing screening is tuned to high-frequency thresholds, which DFNA6/14/38 initially spares, so an affected newborn passes it. The group reporting the largest recent family recommends frequency-specific testing of newborns in known DFNA6/14/38 families instead. This is a family-specific recommendation, not a proposal to change population screening.

Show evidence (1 reference)

PMID:36833385 SUPPORT Human Clinical

"Therefore, we suggest screening newborns in DFNA6/14/38 families with more frequency-specific methods."

The recommendation and, in the preceding sentence of the same abstract, its rationale.

Macular optical coherence tomography

Beyond confirming nerve fibre layer loss, macular optical coherence tomography carries a finding the reporting group described as specific to dominant disease: a linear splitting of the outer plexiform layer, absent in recessive patients in the same series. It is reported from one eight-patient series and has not been replicated independently, so it is recorded as a lead rather than an established discriminator.

Show evidence (1 reference)

PMID:39552476 SUPPORT Human Clinical

"Pathognomonic OPL lamination is associated with dominant disease."

The authors' own summary of the finding. The strength of the word pathognomonic belongs to them; the sample it rests on is eight patients from six families.

📊

Prevalence

1

Worldwide

Unknown Rare

No numeric prevalence estimate exists for nonclassic WFS1-SD as a whole, and none of the sources cited here offers one. What the literature does state is a relative claim - the nonclassic arm is less common than the classic arm - and a qualitative one, that WFS1 is nonetheless the commonest genetic cause of low-frequency non-syndromic hearing loss. Those two are compatible: rare disease, dominant share of a rare audiometric phenotype. measure_type is UNKNOWN because the source states neither a prevalence nor an incidence, and prevalence_class carries the qualitative RARE tier with no rate_per_100000, since putting a band beside a claim with no numerator and no denominator would be an invention. Note that a prevalence figure does exist for classic Wolfram syndrome; it is recorded in the Wolfram_Syndrome entry and does not transfer here.

Show evidence (2 references)

PMID:20301750 SUPPORT Human Clinical

"Nonclassic WFS1-SD is less common than classic WFS1-SD."

The only comparative statement the authoritative source makes about how often the dominant arm occurs.

PMID:36833385 SUPPORT BACKGROUND Human Clinical

"DFNA6/14/38, however, is the most common form of hereditary LFSNHL [9]."

The share-of-phenotype claim, which is a different quantity from population prevalence and should not be read as one.

⚖️

Clinical Burden

Variable

The dominant arm spans two very different burdens, which is why this is VARIABLE rather than a single tier. At one end, DFNA6/14/38 is a lifelong, progressive but non-life-limiting hearing loss confined to one organ, with good speech perception retained for decades. At the other, the aggregating de novo alleles give insulin-requiring diabetes in the first year of life together with congenital deafness, congenital cataract and hypotonia. Wolfram-like syndrome sits between them, adding progressive visual loss to the hearing loss and, in fewer than half of patients, diabetes. The sharpest contrast with classic WFS1-SD is survival. Classic disease is life-limiting through brainstem neurodegeneration; the systematic review of 86 Wolfram-like patients found no study reporting reduced life expectancy. That is an absence of reported evidence in a small, recently delineated literature rather than a demonstration of normal survival, and should be read as such.

Show evidence (2 references)

PMID:36764396 SUPPORT Human Clinical

"There were no studies reporting decreased life expectancy."

The survival statement for the dominant syndromic arm, quoted as the review makes it - as a negative finding about the literature, not a survival measurement.

PMID:36764396 SUPPORT Human Clinical

"This review shows that, within the spectrum of WFS1-associated disorders or "wolframinopathies," autosomal dominantly inherited WFLS has a relatively mild phenotype compared to autosomal recessive WS."

The overall severity comparison between the two arms of the spectrum.

🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from WFS1-Related Disorder:

Classic Wolfram syndrome (recessive WFS1 or CISD2)

Overlapping Features The same gene, and the discriminator is allele dose rather than any single clinical feature. Classic disease needs two inactivating alleles, starts with childhood diabetes mellitus and optic atrophy before 16, and its hearing loss is high-frequency. Dominant disease needs one non-inactivating exon 8 allele, and in its non-syndromic form takes the low frequencies and nothing else. The recessive disease is curated separately in the Wolfram_Syndrome entry, which also covers the CISD2-related form.

Distinguishing Features

Two inactivating WFS1 alleles rather than one non-inactivating exon 8 allele
High-frequency rather than low-frequency hearing loss
Diabetes mellitus and optic atrophy before age 16 as the defining pair

Show evidence (2 references)

PMID:20301750 SUPPORT Human Clinical

"Classic WFS1-SD, a progressive neurodegenerative disorder, is characterized by onset of diabetes mellitus and optic atrophy before age 16 years."

The defining clinical pair and its age limit for the recessive arm.

PMID:21538838 SUPPORT BACKGROUND Human Clinical

"Hearing impairment in Wolfram syndrome is typically progressive and mainly affects the higher frequencies"

The audiometric contrast with the non-syndromic dominant form. BACKGROUND because the sentence summarises earlier work in this paper's introduction.

Other genetic causes of low-frequency non-syndromic hearing loss

Overlapping Features DIAPH1 (DFNA1), CCDC50 (DFNA44), MYO7A (DFNA11) and TNC (DFNA56) can all produce an ascending audiogram, so the audiometric shape narrows the differential without settling it. Of these, MYO7A is curated in this knowledge base as Autosomal Dominant Nonsyndromic Hearing Loss 11.

Distinguishing Features

Pathogenic variant in DIAPH1, CCDC50, MYO7A or TNC rather than WFS1

Show evidence (1 reference)

PMID:37121227 SUPPORT REVIEW SYNTHESIS Human Clinical

"To date, only a handful of genes have been found as causing LFNSHL: well-established WFS1 and, reported in some cases, DIAPH1, MYO7A, TNC, and CCDC50 (respectively, responsible for DFNA6/14/38, DFNA1, DFNA11, DFNA56, and DFNA44)."

The gene list behind this differential. REVIEW_SYNTHESIS because it is a narrative review's compilation rather than a primary result.

{ }

Source YAML

click to show

name: WFS1-Related Disorder
category: Mendelian
creation_date: "2026-09-25T00:00:00Z"
synonyms:
- WFS1 spectrum disorder
- WFS1-SD
- nonclassic WFS1 spectrum disorder
- Wolfram-like syndrome
- WFSL
- DFNA6/14/38
- deafness, autosomal dominant 6/14/38
- WFS1-related low-frequency sensorineural hearing loss
description: >-
  WFS1-related disorder is the whole allelic series of one gene. WFS1 encodes wolframin,
  a multipass endoplasmic-reticulum membrane glycoprotein that holds endoplasmic-reticulum
  calcium stores, restrains the unfolded protein response, and maintains
  mitochondria-associated endoplasmic reticulum membranes. GeneReviews divides the series
  in two: classic WFS1 spectrum disorder, the recessive DIDMOAD neurodegeneration, and
  nonclassic WFS1 spectrum disorder, a set of milder dominant phenotypes caused by a single
  heterozygous variant.

  The split is not a severity gradient, it is an allele-type distinction. Classic disease
  needs two inactivating alleles and is a loss of function. A heterozygous carrier of a
  truncating WFS1 allele generally hears normally, so haploinsufficiency does not produce
  the dominant disease. Every variant unambiguously associated with dominant disease is
  instead a missense change or a small in-frame deletion in exon 8, the last and largest
  exon, which codes for the transmembrane and C-terminal domains. The favoured reading is
  that these non-inactivating alleles interfere with the wild-type protein they are
  co-expressed with, with a toxic gain of function as the stated alternative; neither has
  been settled.

  The dominant arm is clinically heterogeneous in a way the gene alone does not predict.
  Some alleles give isolated low-frequency sensorineural hearing loss at 2 kHz and below
  (DFNA6/14/38) that worsens for decades without reaching profound deafness. Others give
  Wolfram-like syndrome, which adds optic atrophy and adult-onset diabetes to the hearing
  loss. The recurrent allele p.A684V cuts across both: it was the commonest allele in the
  series that defined dominant optic atrophy with hearing loss, and in the largest
  audiological series it gave severe-to-profound congenital hearing loss with optic
  atrophy in only two of eleven assessed patients and diabetes in none. A third group of
  de novo missense alleles, which aggregate and induce
  robust endoplasmic reticulum stress in vitro, cause neonatal or infancy-onset diabetes
  with congenital deafness, cataracts and hypotonia.

  Two things the field cannot yet explain are worth stating plainly, because they are the
  shape of the open problem rather than gaps in this entry. Nobody knows why some exon 8
  missense alleles give syndromic and others non-syndromic disease. And nobody knows why
  the non-syndromic form spares the high frequencies that the syndromic forms damage:
  wolframin is expressed without a basal-to-apical gradient along the cochlea, so the
  audiogram shape is not explained by where the protein is.
disease_term:
  preferred_term: WFS1 spectrum disorder
  term:
    id: MONDO:0700293
    label: WFS1-related disorder
parents:
- Hereditary Hearing Loss
- Monogenic Diabetes
- Neurodegenerative Disease
references:
- reference: PMID:20301750
  title: WFS1 Spectrum Disorder.
  tags:
  - GeneReviews
- reference: PMID:11709537
  title: "Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss."
- reference: PMID:11709538
  title: "Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1."
- reference: PMID:21538838
  title: "Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment."
- reference: PMID:28468959
  title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
- reference: PMID:36833385
  title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
- reference: PMID:37121227
  title: "Monogenic Causes of Low-Frequency Non-Syndromic Hearing Loss."
- reference: PMID:38651637
  title: "The Wolfram-like variant WFS1(E864K) destabilizes MAM and compromises autophagy and mitophagy in human and mice."
- reference: PMID:39552476
  title: "The phenotypic spectrum of syndromic optic atrophy associated with variants in WFS1: with reclassification of p.Val606Gly as a likely benign variant."
- reference: PMID:39858604
  title: "The Heterozygous p.A684V Variant in the WFS1 Gene Is a Mutational Hotspot Causing a Severe Hearing Loss Phenotype."
- reference: PMID:12649740
  title: "The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells."
- reference: PMID:41048689
  title: "Wolfram-like Syndrome: Shedding Light on a Variant of Wolfram Syndrome."
- reference: PMID:36764396
  title: "Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum."
has_subtypes:
- name: Classic WFS1-SD
  display_name: Classic WFS1 spectrum disorder (biallelic, DIDMOAD)
  subtype_term:
    preferred_term: Wolfram syndrome 1
    term:
      id: MONDO:0009101
      label: Wolfram syndrome 1
  description: >-
    The recessive arm: biallelic inactivating WFS1 variants producing childhood-onset
    insulin-dependent diabetes mellitus and optic atrophy, then high-frequency
    sensorineural hearing loss, central diabetes insipidus, neurogenic bladder, and
    brainstem neurodegeneration. It is listed here because it is part of the same MONDO
    concept and the same allelic series, but its mechanism, natural history, treatments
    and trials are curated in full in the separate Wolfram_Syndrome entry, which covers
    the CISD2-related form as well. Everything below in this entry is about the dominant
    arm unless it says otherwise.
  genes:
  - preferred_term: WFS1
    term:
      id: hgnc:12762
      label: WFS1
  evidence:
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Classic WFS1-SD is caused by biallelic WFS1 pathogenic variants and is inherited in an autosomal recessive manner."
    explanation: >-
      Defines the classic arm by allele dose and inheritance, which is what separates it
      from the rest of the series.
- name: DFNA6/14/38
  display_name: DFNA6/14/38 low-frequency nonsyndromic sensorineural hearing loss
  subtype_term:
    preferred_term: autosomal dominant nonsyndromic hearing loss 6
    term:
      id: MONDO:0010963
      label: autosomal dominant nonsyndromic hearing loss 6
  description: >-
    Isolated, dominantly inherited low-frequency sensorineural hearing loss at 2 kHz and
    below, with no optic atrophy, diabetes or other syndromic feature. Three separate
    deafness loci - DFNA6, DFNA14 and DFNA38 - turned out to be the same gene. Onset ranges
    from congenital to the fifth decade and the loss worsens over time without reaching
    profound deafness. This is the most common form of hereditary low-frequency hearing
    loss.
  genes:
  - preferred_term: WFS1
    term:
      id: hgnc:12762
      label: WFS1
  evidence:
  - reference: PMID:11709537
    reference_title: "Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Herein we report five different heterozygous missense mutations (T699M, A716T, V779M, L829P, G831D) in the WFS1 gene found in six LFSNHL families."
    explanation: >-
      The founding observation that heterozygous WFS1 missense alleles cause isolated
      low-frequency hearing loss.
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "The DFNA6, DFNA14 and DFNA38 loci were initially reported separately but were later found to be associated with pathogenic variants in the same gene: WFS1"
    explanation: >-
      Why the subtype carries three locus names. BACKGROUND because this paper restates the
      earlier mapping work rather than reporting it.
- name: Wolfram-like Syndrome
  display_name: Wolfram-like syndrome (autosomal dominant)
  subtype_term:
    preferred_term: Wolfram-like syndrome
    term:
      id: MONDO:0013673
      label: Wolfram-like syndrome
  description: >-
    Dominantly inherited sensorineural hearing loss with optic atrophy and, variably,
    diabetes mellitus - the classic triad in attenuated, incomplete and often later-onset
    form. The recurrent allele p.A684V accounts for a large share of reported families, and
    p.E864K is the allele whose cellular phenotype has been taken apart in most detail.
  genes:
  - preferred_term: WFS1
    term:
      id: hgnc:12762
      label: WFS1
  evidence:
  - reference: PMID:41048689
    reference_title: "Wolfram-like Syndrome: Shedding Light on a Variant of Wolfram Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Wolfram-like syndrome is an autosomal dominant disorder related to classical autosomal recessive Wolfram syndrome. It is characterized by diabetes mellitus, optic atrophy, and sensorineural hearing loss, but typically presents with milder or incomplete features."
    explanation: Defines the subtype and its relationship to the recessive disease.
  - reference: PMID:21538838
    reference_title: "Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among these families, we found three heterozygous missense mutations in WFS1 segregating with OA and SNHL: p.A684V (six families), and two novel mutations, p.G780S and p.D797Y, all involving evolutionarily conserved amino acids and absent from 298 control chromosomes."
    explanation: >-
      Establishes dominant optic atrophy plus hearing loss as a WFS1 phenotype and names the
      recurrent allele.
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Phenotypes that appear to be milder than classic WFS1-SD include: optic atrophy and hearing impairment"
    explanation: >-
      The reference chapter listing this combination among the nonclassic phenotypes,
      which is what places the subtype inside WFS1-SD rather than beside it.
  - reference: PMID:36764396
    reference_title: "Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In total, 86 patients from 35 studies were included. The most common phenotype consisted of the combination of optic atrophy (87%) and hearing impairment (94%)."
    explanation: >-
      The only pooled description of this subtype, and the source of the feature
      frequencies recorded under phenotypes.
- name: Neonatal Diabetes-Deafness-Cataract
  display_name: WFS1 neonatal/infancy-onset diabetes with congenital deafness and cataracts
  subtype_term:
    preferred_term: neonatal diabetes, congenital sensorineural hearing loss and congenital cataracts
    term:
      id: MONDO:0100072
      label: neonatal diabetes, congenital sensorineural hearing loss and congenital cataracts
  description: >-
    The most severe dominant presentation and the one that is usually de novo: diabetes
    diagnosed before twelve months, sensorineural deafness found soon after birth,
    congenital cataracts and hypotonia. The alleles behind it behave differently in vitro
    from recessive Wolfram alleles - they aggregate and induce robust endoplasmic reticulum
    stress rather than simply failing - which is why the reporting group called it a
    discrete pathophysiology rather than severe Wolfram syndrome.
  genes:
  - preferred_term: WFS1
    term:
      id: hgnc:12762
      label: WFS1
  evidence:
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."
    explanation: The defining feature set of this subtype, with its per-feature counts.
inheritance:
- name: Autosomal dominant (nonclassic WFS1-SD)
  description: >-
    A single heterozygous WFS1 variant is sufficient. It may be transmitted from an
    affected parent or arise de novo; for the recurrent p.A684V allele de novo occurrence
    is the rule rather than the exception, confirmed in seven of thirteen families in the
    largest series.

    Dominance here is a statement about the allele, not only about the pedigree. Carriers
    of truncating WFS1 alleles - the obligate heterozygotes in recessive Wolfram families -
    generally hear normally, so halving wolframin dose does not cause the disease. The
    dominant alleles are missense changes and small in-frame deletions in exon 8.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nonclassic WFS1-SD is caused by a heterozygous pathogenic variant and can either be inherited in an autosomal dominant manner from an affected parent or result from a de novo WFS1 pathogenic variant."
    explanation: States the mode of inheritance and both routes to a heterozygous variant.
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Heterozygous carriers of truncating variants generally do not have HL; a heterozygous inactivating variant thus does not lead to a phenotype."
    explanation: >-
      The argument that dominance here cannot be haploinsufficiency, which is what makes
      the allele type, rather than allele dose alone, the discriminator.
  - reference: PMID:39858604
    reference_title: "The Heterozygous p.A684V Variant in the WFS1 Gene Is a Mutational Hotspot Causing a Severe Hearing Loss Phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among the 14 patients from 13 families with the p.A684V variant, nine were sporadic cases. In addition, we confirmed de novo occurrence of this variant in seven families."
    explanation: >-
      Quantifies how often the commonest dominant allele arises de novo, which is why a
      negative family history does not argue against this diagnosis.
- name: Autosomal recessive (classic WFS1-SD)
  description: >-
    The classic arm needs two inactivating WFS1 alleles. It is recorded here for
    completeness of the allelic series; the recessive disease itself is curated in the
    Wolfram_Syndrome entry.
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  evidence:
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Classic WFS1-SD is caused by biallelic WFS1 pathogenic variants and is inherited in an autosomal recessive manner."
    explanation: The inheritance statement for the classic arm.
pathophysiology:
- name: Heterozygous Non-Inactivating WFS1 Variant in Exon 8
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  description: >-
    The initiating lesion of the dominant arm. Every variant unambiguously associated with
    dominant WFS1 disease, syndromic or not, is a missense change or a small in-frame
    deletion in exon 8, the last and largest exon, which encodes the transmembrane and
    C-terminal domains of wolframin. Truncating alleles in the heterozygous state do not
    cause the disease, so this is not a dose lesion: the mutant protein has to be made for
    the phenotype to appear.
  genetic_context:
    variant_origin: GERMLINE
    functional_impact_category: UNKNOWN
    notes: >-
      variant_origin is GERMLINE rather than DE_NOVO because the node covers both routes:
      transmitted from an affected parent, and arising de novo, which is the rule for
      p.A684V and for the alleles behind the neonatal-diabetes subtype. GERMLINE is the
      superset and asserts only what is true of every allele in the node.

      functional_impact_category is UNKNOWN rather than DOMINANT_NEGATIVE because the
      literature offers two competing readings and settles neither. The group that states
      the argument most explicitly proposes dominant-negative interference with the
      wild-type protein and then names a toxic gain of function as the alternative in the
      same paragraph. Recording either value would assert a resolution nobody has reached;
      the two candidate mechanisms are modelled as separate downstream nodes instead.
  genes:
  - preferred_term: WFS1
    term:
      id: hgnc:12762
      label: WFS1
  downstream:
  - target: Mutant Wolframin Interference with Wild-Type Wolframin
    causal_link_type: UNKNOWN
    description: >-
      The dominant-negative reading, argued from the absence of a phenotype in truncating
      heterozygotes rather than demonstrated biochemically.
    evidence:
    - reference: PMID:36833385
      reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "are non-inactivating variants with a dominant-negative effect in which the mutant protein impairs the function of the wild-type protein"
      explanation: >-
        States the dominant-negative reading. INDIRECT because the argument runs from the
        absent phenotype of truncating carriers to the mechanism of missense alleles
        rather than from a measurement of interference.
    - reference: PMID:36833385
      reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "Alternatively, the aberrant protein has a toxic gain-of-function effect."
      explanation: >-
        The competing reading, quoted separately because a bracketed reference marker
        sits between the two sentences and the snippet validator strips it. It is why
        this edge is causal_link_type UNKNOWN, why the node it feeds is HYPOTHETICAL,
        and why functional_impact_category on the upstream node is UNKNOWN.
  - target: Mutant Wolframin Aggregation and Endoplasmic Reticulum Stress
    causal_link_type: DIRECT
    description: >-
      The measured route for the de novo alleles causing neonatal diabetes with congenital
      deafness and cataracts.
    evidence:
    - reference: PMID:28468959
      reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "In vitro studies showed that these WFS1 mutations are functionally different from the known recessive Wolfram syndrome-causing mutations, as they tend to aggregate and induce robust endoplasmic reticulum stress."
      explanation: >-
        Shows the dominant alleles doing something the recessive ones do not, which is the
        experimental basis for treating this as a separate mechanism rather than a severity
        tier.
  - target: Reduced Steady-State Wolframin Level
    causal_link_type: DIRECT
    description: >-
      A third route, measured for the recurrent p.A684V allele: the mutant protein is
      present at lower levels than wild type when expressed in cells.
    evidence:
    - reference: PMID:21538838
      reference_title: "Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "wolframin p.A684V mutant ectopically expressed in HEK cells showed reduced protein levels compared to wild-type wolframin, strongly indicating that the mutation is disease-causing."
      explanation: The measurement behind this node, in the allele it was made on.
  evidence:
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All variants indisputably associated with autosomal dominantly inherited disease, both syndromic (Wolfram-like syndrome) and non-syndromic (DFNA6/14/38), are missense variants or small in-frame deletions located in exon 8."
    explanation: >-
      Locates the dominant alleles in the gene and states their type, which is the content
      of this node.
- name: Mutant Wolframin Interference with Wild-Type Wolframin
  biological_scale: MOLECULAR
  mechanism_confidence: HYPOTHETICAL
  description: >-
    The proposed dominant-negative step: mutant wolframin, made and retained rather than
    degraded, impairs the function of the wild-type protein it is co-expressed with. This
    node is deliberately marked HYPOTHETICAL. No published experiment in this literature
    demonstrates the interaction; it is an inference from the fact that losing one allele
    outright causes nothing while making one abnormal protein causes disease.
  downstream:
  - target: Loss of Endoplasmic Reticulum Calcium Homeostasis and MAM Integrity
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Heterozygous carriers of truncating variants generally do not have HL; a heterozygous inactivating variant thus does not lead to a phenotype."
    explanation: >-
      The observation the hypothesis rests on. INDIRECT because it is a negative clinical
      observation about a different allele class, not a measurement of interference.
- name: Mutant Wolframin Aggregation and Endoplasmic Reticulum Stress
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  description: >-
    The de novo alleles behind neonatal diabetes with congenital deafness and cataracts
    aggregate and drive a strong unfolded protein response, which is the opposite of what
    a simple null does. This is the node that makes the severe dominant presentation a
    different mechanism rather than a worse version of the recessive one.
  biological_processes:
  - preferred_term: endoplasmic reticulum unfolded protein response
    term:
      id: GO:0030968
      label: endoplasmic reticulum unfolded protein response
    modifier: INCREASED
  - preferred_term: response to endoplasmic reticulum stress
    term:
      id: GO:0034976
      label: response to endoplasmic reticulum stress
    modifier: INCREASED
  cellular_components:
  - preferred_term: endoplasmic reticulum membrane
    term:
      id: GO:0005789
      label: endoplasmic reticulum membrane
  downstream:
  - target: Pancreatic Beta-Cell Failure
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  - target: Lens Fibre Opacification
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Profound congenital deafness
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In vitro studies showed that these WFS1 mutations are functionally different from the known recessive Wolfram syndrome-causing mutations, as they tend to aggregate and induce robust endoplasmic reticulum stress."
    explanation: The experimental statement of this node.
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This syndrome has a discrete pathophysiology and differs genetically and clinically from recessive Wolfram syndrome."
    explanation: >-
      The authors' own reading of what that difference means for nosology, which is why
      this subtype is not folded into classic disease.
- name: Reduced Steady-State Wolframin Level
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: >-
    Ectopically expressed p.A684V wolframin is present at lower levels than wild type. How
    this squares with dominance is not resolved in the reporting paper: a lower level of a
    mutant protein is not by itself an explanation for why one abnormal allele is worse
    than one absent allele.
  downstream:
  - target: Loss of Endoplasmic Reticulum Calcium Homeostasis and MAM Integrity
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:21538838
    reference_title: "Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "wolframin p.A684V mutant ectopically expressed in HEK cells showed reduced protein levels compared to wild-type wolframin, strongly indicating that the mutation is disease-causing."
    explanation: The single measurement this node records.
- name: Loss of Endoplasmic Reticulum Calcium Homeostasis and MAM Integrity
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  description: >-
    Wolframin is a resident of the mitochondria-associated endoplasmic reticulum membrane,
    the contact site across which calcium moves from the endoplasmic reticulum to the
    mitochondrion. The Wolfram-like allele p.E864K reduces mitochondrial calcium uptake and
    bioenergetics in human fibroblasts and mouse neurons, and the knock-in mouse has fewer
    contact sites. This is the node at which the dominant and recessive arms converge: the
    same compartment fails, reached by a different route.
  biological_processes:
  - preferred_term: endoplasmic reticulum calcium ion homeostasis
    term:
      id: GO:0032469
      label: endoplasmic reticulum calcium ion homeostasis
    modifier: DECREASED
  cellular_components:
  - preferred_term: mitochondria-associated endoplasmic reticulum membrane
    term:
      id: GO:0044233
      label: mitochondria-associated endoplasmic reticulum membrane contact site
  downstream:
  - target: Mitochondrial Dysfunction with Deregulated Autophagy and Mitophagy
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:38651637
      reference_title: "The Wolfram-like variant WFS1(E864K) destabilizes MAM and compromises autophagy and mitophagy in human and mice."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "Here, we show that in human fibroblasts and murine neuronal cultures the WLS protein WFS1E864K leads to decreases in mitochondria bioenergetics and Ca2+ uptake, deregulation of the mitochondrial quality system mechanisms, and alteration of the autophagic flux."
      explanation: >-
        Reports the calcium and mitochondrial defects together in the same cells, which is
        what this edge asserts.
  - target: Impaired Inner Ear Ion Homeostasis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Proposed rather than demonstrated: wolframin sits in the endoplasmic reticulum of
      inner ear cells in a pattern matching the canalicular reticulum, the specialisation
      implicated in transcellular ion movement.
    evidence:
    - reference: PMID:12649740
      reference_title: "The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: "Although there is nothing currently known about the function of wolframin, our results suggest that it may play a role in inner ear ion homeostasis as maintained by the canalicular reticulum."
      explanation: >-
        The authors state this as a suggestion from a localisation study in mouse inner
        ear, not as a measured function, so the edge is INDIRECT and the node it feeds is
        marked HYPOTHETICAL.
  - target: Retinal Ganglion Cell and Optic Nerve Degeneration
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Pancreatic Beta-Cell Failure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:38651637
    reference_title: "The Wolfram-like variant WFS1(E864K) destabilizes MAM and compromises autophagy and mitophagy in human and mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Moreover, in the Wfs1E864K mouse, these alterations are concomitant with a decrease of MAM number."
    explanation: >-
      The structural counterpart of the functional defect, measured in the knock-in animal
      carrying a human Wolfram-like allele.
  - reference: PMID:38651637
    reference_title: "The Wolfram-like variant WFS1(E864K) destabilizes MAM and compromises autophagy and mitophagy in human and mice."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "These findings reveal pathophysiological similarities between WS and WLS, highlighting the importance of WFS1 for MAM's integrity and functionality."
    explanation: >-
      States the convergence between the dominant and recessive arms at this compartment,
      which is the reason this node is shared rather than split.
- name: Mitochondrial Dysfunction with Deregulated Autophagy and Mitophagy
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  description: >-
    Downstream of the contact-site defect: reduced mitochondrial bioenergetics, a
    deregulated mitochondrial quality-control system, and altered autophagic flux, shown
    for p.E864K in human fibroblasts, mouse neurons and the knock-in mouse.
  biological_processes:
  - preferred_term: autophagy
    term:
      id: GO:0006914
      label: autophagy
    modifier: DYSREGULATED
  - preferred_term: mitophagy
    term:
      id: GO:0000423
      label: mitophagy
    modifier: DYSREGULATED
  downstream:
  - target: Retinal Ganglion Cell and Optic Nerve Degeneration
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:38651637
    reference_title: "The Wolfram-like variant WFS1(E864K) destabilizes MAM and compromises autophagy and mitophagy in human and mice."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Here, we show that in human fibroblasts and murine neuronal cultures the WLS protein WFS1E864K leads to decreases in mitochondria bioenergetics and Ca2+ uptake, deregulation of the mitochondrial quality system mechanisms, and alteration of the autophagic flux."
    explanation: The measurements this node records, in two cell systems.
- name: Impaired Inner Ear Ion Homeostasis
  biological_scale: TISSUE
  mechanism_confidence: HYPOTHETICAL
  description: >-
    The step between the cellular defect and the audiogram, and the weakest link in the
    chain. Wolframin is present in the endoplasmic reticulum of many inner ear cell types,
    in a distribution resembling the canalicular reticulum that is thought to handle
    transcellular ion movement, so an ion-homeostasis failure is the natural candidate. It
    has not been measured in a WFS1 ear. Crucially, expression shows no basal-to-apical
    gradient along the cochlea, so this node as stated does not explain why the
    non-syndromic form takes the low frequencies and the syndromic forms take the high
    ones.
  locations:
  - preferred_term: internal ear
    term:
      id: UBERON:0001846
      label: internal ear
  - preferred_term: cochlea
    term:
      id: UBERON:0001844
      label: cochlea
  downstream:
  - target: Low-frequency sensorineural hearing loss
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Progressive sensorineural hearing impairment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Congenital severe-to-profound sensorineural hearing impairment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Tinnitus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:12649740
    reference_title: "The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Double immunostaining with an endoplasmic reticulum marker confirmed that wolframin localizes to this organelle."
    explanation: Places the protein in the compartment this node is about, in the inner ear.
  - reference: PMID:12649740
    reference_title: "The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Although there were observable developmental differences, no differences in staining pattern or gradients of expression were observed between the basal and apical parts of the cochlea."
    explanation: >-
      The negative result that keeps this node from explaining the audiogram shape: there
      is no expression gradient to map onto a frequency gradient.
- name: Pancreatic Beta-Cell Failure
  biological_scale: CELLULAR
  mechanism_confidence: PROVISIONAL
  description: >-
    Insulin-secreting beta cells are among the cells that depend most on wolframin, and in
    the dominant arm their failure ranges from neonatal insulin-requiring diabetes with the
    aggregating alleles to adult-onset diabetes in Wolfram-like syndrome. The step from the
    cellular defect to beta-cell loss is inferred from the clinical phenotype and from the
    recessive disease; no dominant-allele beta-cell experiment is cited here.
  cell_types:
  - preferred_term: pancreatic beta cell
    term:
      id: CL:0000169
      label: type B pancreatic cell
  biological_processes:
  - preferred_term: glucose homeostasis
    term:
      id: GO:0042593
      label: glucose homeostasis
    modifier: DECREASED
  downstream:
  - target: Neonatal insulin-dependent diabetes mellitus
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  - target: Diabetes mellitus
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our results establish specific dominant WFS1 mutations as a cause of a novel syndrome including neonatal/infancy-onset diabetes, congenital cataracts, and sensorineural deafness."
    explanation: >-
      Establishes that dominant WFS1 alleles cause insulin-requiring diabetes in the first
      year of life, which is the clinical read-out of this node at its most severe.
- name: Retinal Ganglion Cell and Optic Nerve Degeneration
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  description: >-
    Optic atrophy in the dominant arm is retinal nerve fibre layer loss, and in the largest
    ophthalmic series it is accompanied by a finding not seen in recessive disease: a
    linear splitting of the outer plexiform layer on macular optical coherence tomography.
    Several patients in that series were asymptomatic, so this node can be present before
    the patient notices anything.
  cell_types:
  - preferred_term: retinal ganglion cell
    term:
      id: CL:0000740
      label: retinal ganglion cell
  downstream:
  - target: Optic atrophy
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:39552476
    reference_title: "The phenotypic spectrum of syndromic optic atrophy associated with variants in WFS1: with reclassification of p.Val606Gly as a likely benign variant."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "OCT demonstrated marked nerve fiber layer loss in all patients."
    explanation: The structural measurement behind this node in the reported cohort.
  - reference: PMID:39552476
    reference_title: "The phenotypic spectrum of syndromic optic atrophy associated with variants in WFS1: with reclassification of p.Val606Gly as a likely benign variant."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In dominant disease, macular OCT demonstrated a linear splitting abnormality of the outer plexiform layer (OPL) not found in recessive disease."
    explanation: >-
      A retinal finding specific to the dominant arm, which is the one place in this entry
      where the two arms differ structurally rather than only clinically.
- name: Lens Fibre Opacification
  biological_scale: TISSUE
  mechanism_confidence: HYPOTHETICAL
  description: >-
    Congenital cataract in the aggregating-allele subtype. The lens is included because the
    phenotype is consistent across the reported patients, not because a lens experiment
    exists; no cited work measures wolframin handling in lens fibre cells.
  cell_types:
  - preferred_term: lens fiber cell
    term:
      id: CL:0011004
      label: lens fiber cell
  downstream:
  - target: Congenital cataract
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."
    explanation: The clinical observation of lens involvement, with its denominator.
phenotypes:
- name: Low-frequency sensorineural hearing loss
  category: Auditory
  subtype: DFNA6/14/38
  description: >-
    The defining feature of the non-syndromic dominant subtype: a sensorineural loss
    confined at first to 2 kHz and below, giving an ascending audiogram, worsening over
    decades without reaching profound deafness. In the largest recently phenotyped family
    the loss sat at roughly 50-60 dB HL across 0.25-2 kHz at every age, with the higher
    frequencies varying between individuals.
  frequency: OBLIGATE
  phenotype_term:
    preferred_term: Low-frequency sensorineural hearing loss
    term:
      id: HP:0008542
      label: Low-frequency hearing loss
  evidence:
  - reference: PMID:11709537
    reference_title: "Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Non-syndromic low frequency sensorineural hearing loss (LFSNHL) affecting only 2000 Hz and below is an unusual type of hearing loss that worsens over time without progressing to profound deafness."
    explanation: Defines the audiometric shape and the natural history of this phenotype.
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At all ages, an LFSNHL (0.25-2 kHz) of about 50-60 decibel hearing level (dB HL) was observed."
    explanation: The measured severity and frequency range in a large recently studied family.
  - reference: PMID:37121227
    reference_title: "Monogenic Causes of Low-Frequency Non-Syndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "LFNSHL is most commonly caused by pathogenic variants in the WFS1 gene, but it is also important to consider changes in other HL genes, which may result in similar audiological phenotype."
    explanation: >-
      Places WFS1 as the leading cause of this audiometric phenotype, and names the caveat
      that the audiogram alone does not make the diagnosis. REVIEW_SYNTHESIS because this
      is a narrative review's summary rather than its own cohort.
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "and isolated congenital, slowly progressive, and low-frequency (<2000 Hz) sensorineural hearing loss"
    explanation: >-
      The reference chapter's own listing of this presentation among the nonclassic
      phenotypes, and the source of the below-2000 Hz boundary used throughout this entry.
- name: Progressive sensorineural hearing impairment
  category: Auditory
  description: >-
    The hearing loss of the dominant arm worsens rather than staying fixed, and the age at
    which it declares itself is strikingly variable even inside one family - from
    congenital to the fifth decade in the family with p.Pro838Ser. The practical
    consequence is that newborn hearing screening does not exclude it, because the
    high-frequency thresholds screening programmes are tuned to are initially preserved.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Progressive sensorineural hearing impairment
    term:
      id: HP:0000408
      label: Progressive sensorineural hearing impairment
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:11709538
    reference_title: "Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Dominantly inherited progressive hearing loss DFNA38 is caused by heterozygosity for a novel mutation in WFS1, the gene for recessively inherited Wolfram syndrome."
    explanation: States progression as part of the definition of the DFNA38 phenotype.
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The self-reported age of onset of hearing loss (HL) ranged from congenital to 50 years of age."
    explanation: The range of onset ages within a single family carrying one allele.
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We would like to emphasize that conventional neonatal hearing screening programs are not sensitive to HL in DFNA6/14/38 patients, because high-frequency hearing thresholds are initially preserved."
    explanation: >-
      The screening consequence, which is the clinically actionable part of this
      phenotype.
- name: Congenital severe-to-profound sensorineural hearing impairment
  category: Auditory
  description: >-
    The p.A684V allele breaks the usual dominant pattern. Instead of a mild ascending
    audiogram it gives congenital or very early, severe-to-profound bilateral loss, and it
    arises de novo often enough that most probands have no family history. This is the
    genotype-phenotype correlation with the clearest management consequence in the entry.
  notes: >-
    Deliberately not scoped to a subtype, and deliberately carrying no frequency. The
    allele spans the subtype boundary: it is the commonest allele in the series that
    defined Wolfram-like dominant optic atrophy with hearing loss, while in the
    fourteen-patient audiological series most carriers had hearing loss and nothing else -
    optic atrophy in two of eleven assessed, diabetes in none. Recording it under
    Wolfram-like syndrome would assert a syndromic presentation most of those patients did
    not have. A frequency would need a denominator across the whole entity, and the only
    denominators published are per-allele.
  phenotype_term:
    preferred_term: Congenital severe-to-profound sensorineural hearing impairment
    term:
      id: HP:0008527
      label: Congenital sensorineural hearing impairment
  evidence:
  - reference: PMID:39858604
    reference_title: "The Heterozygous p.A684V Variant in the WFS1 Gene Is a Mutational Hotspot Causing a Severe Hearing Loss Phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The identified heterozygous p.A684V variant appears to be a hotspot mutation and likely to cause severe-to-profound hearing loss in early childhood."
    explanation: The conclusion of the largest series assembled for this allele.
  - reference: PMID:39858604
    reference_title: "The Heterozygous p.A684V Variant in the WFS1 Gene Is a Mutational Hotspot Causing a Severe Hearing Loss Phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "In DFNA6/14/38 cases, hearing loss primarily affects low frequencies and progresses slowly without reaching a severe-to-profound range"
    explanation: >-
      The contrast that makes this a distinct phenotype rather than the same one more
      severely expressed. BACKGROUND because the sentence restates the established DFNA6
      picture rather than reporting this study's own patients.
- name: Optic atrophy
  category: Ophthalmic
  subtype: Wolfram-like Syndrome
  description: >-
    Optic atrophy is what turns dominant WFS1 hearing loss into Wolfram-like syndrome. In
    the reported ophthalmic series it presented in adolescence or early adulthood, was
    asymptomatic in several patients, and showed marked retinal nerve fibre layer loss on
    optical coherence tomography in all of them.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Optic atrophy
    term:
      id: HP:0000648
      label: Optic atrophy
  evidence:
  - reference: PMID:39552476
    reference_title: "The phenotypic spectrum of syndromic optic atrophy associated with variants in WFS1: with reclassification of p.Val606Gly as a likely benign variant."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Eight patients (six female, two male) from six families were diagnosed with optic atrophy at a mean age of 15.5 ± 6.2 years (range 8-23) with mean follow-up of 3.2 ± 3.4 years (range 1.5-12.1). Three were asymptomatic."
    explanation: >-
      Age at diagnosis and the proportion presenting without symptoms, which is why this
      phenotype is found by screening rather than by complaint.
  - reference: PMID:21538838
    reference_title: "Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our data support OA and SNHL as a phenotype caused by dominant mutations in WFS1 in these additional eight families."
    explanation: Establishes optic atrophy with hearing loss as a dominant WFS1 phenotype.
  - reference: PMID:36764396
    reference_title: "Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The most common phenotype consisted of the combination of optic atrophy (87%) and hearing impairment (94%)."
    explanation: >-
      The pooled frequency across 86 reported Wolfram-like patients, which is what
      frequency VERY_FREQUENT records here.
- name: Diabetes mellitus
  category: Endocrine
  subtype: Wolfram-like Syndrome
  description: >-
    In the dominant arm diabetes is variable and often later in onset than the childhood
    diabetes of classic disease - in one reported Wolfram-like patient it was diagnosed in
    his fifties and managed with metformin. In the ophthalmic series it was present in five
    of eight patients, one of whom was found only on screening after the optic atrophy was
    recognised.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Diabetes mellitus
    term:
      id: HP:0000819
      label: Diabetes mellitus
  evidence:
  - reference: PMID:39552476
    reference_title: "The phenotypic spectrum of syndromic optic atrophy associated with variants in WFS1: with reclassification of p.Val606Gly as a likely benign variant."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Diabetes mellitus was present in five patients (detected after screening in one), sensorineural hearing loss in five and diabetes insipidus in one."
    explanation: >-
      The frequency of diabetes in a dominant-weighted WFS1 series, and the fact that
      recognising the eye disease found it.
  - reference: PMID:41048689
    reference_title: "Wolfram-like Syndrome: Shedding Light on a Variant of Wolfram Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "He had a known history of diabetes mellitus, diagnosed 2 years prior, managed with metformin 850 mg, half a tablet every 12 hours."
    explanation: >-
      A worked instance of how late and how mild the diabetes of the dominant arm can be -
      non-insulin-requiring at diagnosis in a man in his fifties.
  - reference: PMID:36764396
    reference_title: "Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Diabetes mellitus was seen in 44% of the patients."
    explanation: >-
      The pooled frequency of diabetes in Wolfram-like syndrome, which is markedly lower
      than in classic disease where it is a defining feature.
- name: Neonatal insulin-dependent diabetes mellitus
  category: Endocrine
  subtype: Neonatal Diabetes-Deafness-Cataract
  description: >-
    At the severe end of the dominant arm, diabetes presents in the first year and often in
    the first six months. It was the presenting problem that led to the discovery of this
    subtype through exome sequencing of a patient with unexplained syndromic neonatal
    diabetes.
  frequency: OBLIGATE
  phenotype_term:
    preferred_term: Neonatal insulin-dependent diabetes mellitus
    term:
      id: HP:0000857
      label: Neonatal insulin-dependent diabetes mellitus
  evidence:
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."
    explanation: Age at diagnosis and completeness of penetrance within the reported series.
- name: Profound congenital deafness
  category: Auditory
  subtype: Neonatal Diabetes-Deafness-Cataract
  description: >-
    Deafness found soon after birth in every patient of the defining series, and profound
    in the GeneReviews description of this presentation. It sits at the opposite end of
    the dominant arm's auditory range from the mild ascending audiogram of DFNA6/14/38,
    and unlike that form it is syndromic from the start.
  frequency: OBLIGATE
  phenotype_term:
    preferred_term: Profound congenital deafness
    term:
      id: HP:0011476
      label: Profound sensorineural hearing impairment
  evidence:
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."
    explanation: >-
      Deafness in all five patients of the series that defined this subtype, with the
      timing that makes it congenital.
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "neonatal diabetes, profound congenital deafness, and cataracts"
    explanation: >-
      The GeneReviews description of this nonclassic presentation, which is where the
      severity grading of the hearing loss comes from.
- name: Congenital cataract
  category: Ophthalmic
  subtype: Neonatal Diabetes-Deafness-Cataract
  description: >-
    Congenital lens opacity, present in four of the five originally reported patients with
    the aggregating dominant alleles. It is the feature that most clearly separates this
    subtype from classic Wolfram syndrome, where cataract is not part of the defining
    picture.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Congenital cataract
    term:
      id: HP:0000519
      label: Developmental cataract
  evidence:
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."
    explanation: The count of affected patients within the defining series.
- name: Hypotonia
  category: Neurological
  subtype: Neonatal Diabetes-Deafness-Cataract
  description: >-
    Present in four of the five patients in the defining series. No subsequent
    characterisation of its course has been published, so nothing beyond its presence is
    recorded here.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They had diabetes diagnosed before 12 months (2 before 6 months) (5/5), sensorineural deafness diagnosed soon after birth (5/5), congenital cataracts (4/5), and hypotonia (4/5)."
    explanation: The observation and its denominator.
- name: Tinnitus
  category: Auditory
  subtype: DFNA6/14/38
  description: >-
    Mild tinnitus accompanies the low-frequency loss in some patients. Vertigo does not:
    the founding description explicitly separates this phenotype from vestibular symptoms,
    which matters because a low-frequency fluctuating loss with vertigo points at Meniere
    disease instead.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Tinnitus
    term:
      id: HP:0000360
      label: Tinnitus
  evidence:
  - reference: PMID:11709537
    reference_title: "Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This type of LFSNHL may be associated with mild tinnitus but is not associated with vertigo."
    explanation: >-
      Records both the phenotype and the negative that differentiates it from the commonest
      mimic.
genetic:
- name: WFS1
  notes: >-
    The only gene in this entry. WFS1 at 4p16.1 encodes wolframin, an 890-residue
    endoplasmic-reticulum transmembrane glycoprotein. The dominant alleles of this entry
    sit in exon 8, which encodes the transmembrane and C-terminal domains; more than forty
    variants are on record as causing low-frequency hearing loss alone. The recessive
    alleles that cause classic disease are mostly truncating and are curated in the
    Wolfram_Syndrome entry.
  relationship_type: CAUSATIVE
  gene_term:
    preferred_term: WFS1
    term:
      id: hgnc:12762
      label: WFS1
  evidence:
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All variants indisputably associated with autosomal dominantly inherited disease, both syndromic (Wolfram-like syndrome) and non-syndromic (DFNA6/14/38), are missense variants or small in-frame deletions located in exon 8. This is the last and largest exon of WFS1 and codes for the transmembrane domains and the C-terminal domain of the protein (UniProt accession no. O76024)"
    explanation: >-
      Locates the dominant allele class in the gene and says what that part of the gene
      encodes.
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "Over 40 variants within this gene are known to cause LFSNHL [7]."
    explanation: >-
      The size of the allelic series behind the non-syndromic phenotype. BACKGROUND because
      the count is cited from a variant database rather than produced here.
  - reference: PMID:21538838
    reference_title: "Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "In the dominantly inherited disease, LFSNHL, the WFS1 mutations are mainly missense mutations in exon 8; 28 different missense mutations have been identified"
    explanation: >-
      The earlier count of the same allele series, quoted beside the later one rather than
      reconciled with it. BACKGROUND because it is this paper's framing of prior work.
  - reference: PMID:36764396
    reference_title: "Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Patients with missense mutations in WFS1 had a lower number of clinical manifestations, less chance of developing diabetes insipidus, but a younger age at onset of hearing impairment compared to patients with nonsense mutations or deletions causing frameshift."
    explanation: >-
      A genotype-phenotype correlation inside the dominant arm, and the one place the
      literature separates allele classes by outcome rather than only by inheritance. Note
      it groups heterozygous nonsense and frameshift alleles as a comparison class, which
      sits awkwardly beside the statement that truncating heterozygotes are generally
      unaffected; the review does not reconcile the two and neither does this entry.
prevalence:
- population: Worldwide
  measure_type: UNKNOWN
  prevalence_class: RARE
  notes: >-
    No numeric prevalence estimate exists for nonclassic WFS1-SD as a whole, and none of
    the sources cited here offers one. What the literature does state is a relative claim -
    the nonclassic arm is less common than the classic arm - and a qualitative one, that
    WFS1 is nonetheless the commonest genetic cause of low-frequency non-syndromic hearing
    loss. Those two are compatible: rare disease, dominant share of a rare audiometric
    phenotype.

    measure_type is UNKNOWN because the source states neither a prevalence nor an
    incidence, and prevalence_class carries the qualitative RARE tier with no
    rate_per_100000, since putting a band beside a claim with no numerator and no
    denominator would be an invention. Note that a prevalence figure does exist for classic
    Wolfram syndrome; it is recorded in the Wolfram_Syndrome entry and does not transfer
    here.
  evidence:
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nonclassic WFS1-SD is less common than classic WFS1-SD."
    explanation: >-
      The only comparative statement the authoritative source makes about how often the
      dominant arm occurs.
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "DFNA6/14/38, however, is the most common form of hereditary LFSNHL [9]."
    explanation: >-
      The share-of-phenotype claim, which is a different quantity from population
      prevalence and should not be read as one.
clinical_burden:
  burden_level: VARIABLE
  rationale: >-
    The dominant arm spans two very different burdens, which is why this is VARIABLE rather
    than a single tier. At one end, DFNA6/14/38 is a lifelong, progressive but
    non-life-limiting hearing loss confined to one organ, with good speech perception
    retained for decades. At the other, the aggregating de novo alleles give
    insulin-requiring diabetes in the first year of life together with congenital
    deafness, congenital cataract and hypotonia. Wolfram-like syndrome sits between them, adding
    progressive visual loss to the hearing loss and, in fewer than half of patients,
    diabetes.

    The sharpest contrast with classic WFS1-SD is survival. Classic disease is
    life-limiting through brainstem neurodegeneration; the systematic review of 86
    Wolfram-like patients found no study reporting reduced life expectancy. That is an
    absence of reported evidence in a small, recently delineated literature rather than a
    demonstration of normal survival, and should be read as such.
  evidence:
  - reference: PMID:36764396
    reference_title: "Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There were no studies reporting decreased life expectancy."
    explanation: >-
      The survival statement for the dominant syndromic arm, quoted as the review makes it
      - as a negative finding about the literature, not a survival measurement.
  - reference: PMID:36764396
    reference_title: "Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This review shows that, within the spectrum of WFS1-associated disorders or \"wolframinopathies,\" autosomal dominantly inherited WFLS has a relatively mild phenotype compared to autosomal recessive WS."
    explanation: The overall severity comparison between the two arms of the spectrum.
diagnosis:
- name: Molecular genetic testing for a heterozygous WFS1 variant
  description: >-
    The diagnosis of nonclassic WFS1-SD is made by finding one pathogenic or likely
    pathogenic WFS1 variant in a proband with suggestive findings. Allele dose is what
    separates the two arms diagnostically, not the phenotype: the same gene with two
    inactivating alleles gives classic disease. Because the commonest dominant allele is
    usually de novo, an absent family history does not argue against the diagnosis, and in
    the largest series most probands were sporadic.
  evidence:
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nonclassic WFS1-SD. The diagnosis is established in a proband with suggestive findings and a heterozygous pathogenic (or likely pathogenic) variant identified by molecular genetic testing."
    explanation: The diagnostic criterion for the dominant arm, stated by the reference source.
- name: Frequency-specific audiometry rather than newborn hearing screening
  description: >-
    Standard newborn hearing screening is tuned to high-frequency thresholds, which
    DFNA6/14/38 initially spares, so an affected newborn passes it. The group reporting the
    largest recent family recommends frequency-specific testing of newborns in known
    DFNA6/14/38 families instead. This is a family-specific recommendation, not a proposal
    to change population screening.
  evidence:
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Therefore, we suggest screening newborns in DFNA6/14/38 families with more frequency-specific methods."
    explanation: The recommendation and, in the preceding sentence of the same abstract, its rationale.
- name: Macular optical coherence tomography
  description: >-
    Beyond confirming nerve fibre layer loss, macular optical coherence tomography carries
    a finding the reporting group described as specific to dominant disease: a linear
    splitting of the outer plexiform layer, absent in recessive patients in the same
    series. It is reported from one eight-patient series and has not been replicated
    independently, so it is recorded as a lead rather than an established discriminator.
  evidence:
  - reference: PMID:39552476
    reference_title: "The phenotypic spectrum of syndromic optic atrophy associated with variants in WFS1: with reclassification of p.Val606Gly as a likely benign variant."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pathognomonic OPL lamination is associated with dominant disease."
    explanation: >-
      The authors' own summary of the finding. The strength of the word pathognomonic
      belongs to them; the sample it rests on is eight patients from six families.
treatments:
- name: Cochlear implantation
  description: >-
    For the severe-to-profound congenital hearing loss of the p.A684V allele, cochlear
    implantation is the recommended intervention. In the series reporting that allele, the
    four implanted patients reached a mean aided level of 28.7 dB while the five using
    hearing aids reached 40.9 dB, and the authors note that amplification was insufficient
    in some. This does not generalise to DFNA6/14/38, where the loss is mild-to-moderate
    and low-frequency and speech perception typically stays good.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: cochlear device implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: cochlear implant
        term:
          id: NCIT:C157820
          label: Cochlear Implant
  target_mechanisms:
  - target: Congenital severe-to-profound sensorineural hearing impairment
    description: >-
      The implant bypasses the failing cochlea rather than correcting the wolframin
      defect, so it addresses the phenotype and leaves every other node untouched.
  evidence:
  - reference: PMID:39858604
    reference_title: "The Heterozygous p.A684V Variant in the WFS1 Gene Is a Mutational Hotspot Causing a Severe Hearing Loss Phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cochlear implantation is considered favorable in cases of hearing impairment due to this variant."
    explanation: The recommendation, made specifically for the severe dominant allele.
  - reference: PMID:39858604
    reference_title: "The Heterozygous p.A684V Variant in the WFS1 Gene Is a Mutational Hotspot Causing a Severe Hearing Loss Phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The other four patients received bilateral cochlear implantation, and their hearing levels were improved to 28.7 dB on average (ranging from 22.5 dB to 33.4 dB)."
    explanation: The outcome behind the recommendation, with its sample size visible.
- name: Multidisciplinary supportive care
  description: >-
    There is no cure and no disease-modifying therapy for any part of the WFS1 spectrum.
    Management is supportive and distributed across specialties according to which
    manifestations a given patient has - diabetes care, ophthalmology and low vision,
    audiology and speech-language therapy, neurology, psychiatry, urology and medical
    genetics - with regular monitoring for manifestations that have not yet appeared.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "There is no cure for WFS1-SD."
    explanation: The statement that sets the ceiling on everything in this section.
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Surveillance: For both classic and nonclassic WFS1-SD, regular monitoring of existing manifestations, the response of an individual to supportive care, and the emergence of new manifestations is recommended."
    explanation: >-
      The surveillance recommendation, stated for the dominant arm explicitly and not only
      for classic disease.
- name: Preconception and pregnancy glycaemic management
  description: >-
    Insulin-dependent diabetes is a feature of the dominant arm as well as the recessive
    one, so a pregnant patient carries the raised risk of diabetic embryopathy that goes
    with it - two- to eightfold, by the reference chapter's figure. Optimising glucose
    control before and during pregnancy reduces that risk without abolishing it. The
    diabetes-insipidus monitoring that GeneReviews adds for pregnancy applies to classic
    disease, so it is not carried here.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pregnant women with insulin-dependent diabetes mellitus, a characteristic of both classic and nonclassic WFS1-SD, have a two- to eightfold higher risk of having a child with a birth defect or a pattern of birth defects (diabetic embryopathy) than women who do not have diabetes."
    explanation: >-
      The risk figure and, in the same sentence, the statement that it applies to the
      nonclassic arm and not only to classic disease.
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Optimizing glucose control before and during pregnancy can reduce"
    explanation: The intervention, and the limit the chapter puts on it in the same sentence.
- name: Genetic counseling and testing of at-risk relatives
  description: >-
    Counseling for the dominant arm differs from the recessive arm at every point: a 50%
    risk to offspring of an affected parent rather than a 25% risk to sibs, and a
    de novo-heavy allele spectrum in which an unaffected-parent pedigree is common. Testing
    at-risk relatives is recommended so that diabetes mellitus, optic atrophy and hearing
    loss can be treated as early as possible - which, given how often optic atrophy is
    asymptomatic at diagnosis, is a real yield rather than a formality.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "If a parent of the proband is affected and/or is known to have the pathogenic variant identified in the proband, the risk to sibs of inheriting the pathogenic variant is 50%."
    explanation: The recurrence risk specific to the dominant arm.
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It is appropriate to clarify the genetic status of apparently asymptomatic at-risk relatives in order to identify as early as possible those who would benefit from prompt initiation of treatment for the earliest manifestations of WFS1-SD: diabetes mellitus, optic atrophy, and sensorineural hearing loss."
    explanation: The cascade-testing recommendation and the manifestations it is aimed at.
discussions:
- discussion_id: wfs1_lfsnhl_frequency_specificity
  kind: KNOWLEDGE_GAP
  prompt: >-
    Why does the non-syndromic dominant form of WFS1 disease take the low frequencies while
    the syndromic forms take the high ones, when wolframin is expressed without a
    basal-to-apical gradient along the cochlea?
  rationale: >-
    This is the central unexplained fact of the entry and it constrains the mechanism. A
    frequency-specific audiometric phenotype normally invites a gradient explanation - more
    protein, or more dependence on it, at one end of the cochlea than the other. The one
    localisation study that looked found no such gradient. So either the relevant quantity
    is not expression level, or the lesion acts on something that varies along the cochlea
    for another reason. Until this is settled, the Impaired Inner Ear Ion Homeostasis node
    in this entry cannot account for the phenotype it points at, which is why it is marked
    HYPOTHETICAL.
  attaches_to:
  - pathophysiology#Impaired Inner Ear Ion Homeostasis
  - phenotypes#Low-frequency sensorineural hearing loss
  evidence:
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It is not yet understood why some variants lead to syndromic and others to non-syndromic disease or why DFNA6/14/38 is characterized by LFSNHL, while in most syndromic forms, the higher frequencies are typically affected."
    explanation: The field's own statement of the gap, covering both halves of it.
  - reference: PMID:12649740
    reference_title: "The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Although there were observable developmental differences, no differences in staining pattern or gradients of expression were observed between the basal and apical parts of the cochlea."
    explanation: >-
      The negative result that rules out the obvious explanation, in mouse inner ear.
- discussion_id: wfs1_dominant_allele_mechanism
  kind: KNOWLEDGE_GAP
  prompt: >-
    Do the dominant WFS1 alleles act by interfering with wild-type wolframin, or by a toxic
    gain of function, and does the answer differ between the mild non-syndromic alleles and
    the aggregating de novo ones?
  rationale: >-
    The two readings are offered side by side in the literature and have never been
    separated experimentally for the non-syndromic alleles. They are not interchangeable:
    dominant-negative interference predicts that the phenotype depends on the wild-type
    allele being present and on the two proteins meeting, while toxic gain of function
    predicts a cell-autonomous burden that antisense knockdown of the mutant allele would
    relieve regardless. The aggregating alleles of the neonatal-diabetes subtype do have a
    measured gain-of-function-like behaviour, which is the one point in the series where
    the question has an answer - and it is an answer for one allele class only.
  attaches_to:
  - pathophysiology#Mutant Wolframin Interference with Wild-Type Wolframin
  - pathophysiology#Heterozygous Non-Inactivating WFS1 Variant in Exon 8
  evidence:
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "are non-inactivating variants with a dominant-negative effect in which the mutant protein impairs the function of the wild-type protein"
    explanation: >-
      The dominant-negative reading, which is one of the two candidates this discussion
      is about.
  - reference: PMID:36833385
    reference_title: "Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Alternatively, the aberrant protein has a toxic gain-of-function effect."
    explanation: >-
      The other candidate, from the sentence immediately after the one above. The two
      are quoted separately because a bracketed reference marker between them is
      stripped by the snippet validator.
  - reference: PMID:28468959
    reference_title: "Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In vitro studies showed that these WFS1 mutations are functionally different from the known recessive Wolfram syndrome-causing mutations, as they tend to aggregate and induce robust endoplasmic reticulum stress."
    explanation: >-
      The one allele class where the question has been addressed experimentally, and the
      answer does not transfer to the mild non-syndromic alleles.
differential_diagnoses:
- name: Classic Wolfram syndrome (recessive WFS1 or CISD2)
  description: >-
    The same gene, and the discriminator is allele dose rather than any single clinical
    feature. Classic disease needs two inactivating alleles, starts with childhood diabetes
    mellitus and optic atrophy before 16, and its hearing loss is high-frequency. Dominant
    disease needs one non-inactivating exon 8 allele, and in its non-syndromic form takes
    the low frequencies and nothing else. The recessive disease is curated separately in
    the Wolfram_Syndrome entry, which also covers the CISD2-related form.
  distinguishing_features:
  - Two inactivating WFS1 alleles rather than one non-inactivating exon 8 allele
  - High-frequency rather than low-frequency hearing loss
  - Diabetes mellitus and optic atrophy before age 16 as the defining pair
  evidence:
  - reference: PMID:20301750
    reference_title: WFS1 Spectrum Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Classic WFS1-SD, a progressive neurodegenerative disorder, is characterized by onset of diabetes mellitus and optic atrophy before age 16 years."
    explanation: The defining clinical pair and its age limit for the recessive arm.
  - reference: PMID:21538838
    reference_title: "Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "Hearing impairment in Wolfram syndrome is typically progressive and mainly affects the higher frequencies"
    explanation: >-
      The audiometric contrast with the non-syndromic dominant form. BACKGROUND because the
      sentence summarises earlier work in this paper's introduction.
- name: OPA1-related dominant optic atrophy with deafness
  description: >-
    The main alternative when a patient presents with dominant optic atrophy plus
    sensorineural hearing loss and nothing else. OPA1, most often the recurrent p.R445H
    allele, was for a long time the only gene known to do this, and it was the exclusion of
    that allele in eight families that established WFS1 as a second cause.
  distinguishing_features:
  - Pathogenic OPA1 variant, classically p.R445H, rather than a WFS1 exon 8 missense allele
  evidence:
  - reference: PMID:21538838
    reference_title: "Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Importantly, none of these families harbored the OPA1 p.R445H mutation."
    explanation: >-
      The exclusion that separated the two causes in the cohort that defined the WFS1
      phenotype.
- name: Other genetic causes of low-frequency non-syndromic hearing loss
  description: >-
    DIAPH1 (DFNA1), CCDC50 (DFNA44), MYO7A (DFNA11) and TNC (DFNA56) can all produce an
    ascending audiogram, so the audiometric shape narrows the differential without settling
    it. Of these, MYO7A is curated in this knowledge base as Autosomal Dominant Nonsyndromic
    Hearing Loss 11.
  distinguishing_features:
  - Pathogenic variant in DIAPH1, CCDC50, MYO7A or TNC rather than WFS1
  evidence:
  - reference: PMID:37121227
    reference_title: "Monogenic Causes of Low-Frequency Non-Syndromic Hearing Loss."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "To date, only a handful of genes have been found as causing LFNSHL: well-established WFS1 and, reported in some cases, DIAPH1, MYO7A, TNC, and CCDC50 (respectively, responsible for DFNA6/14/38, DFNA1, DFNA11, DFNA56, and DFNA44)."
    explanation: >-
      The gene list behind this differential. REVIEW_SYNTHESIS because it is a narrative
      review's compilation rather than a primary result.
notes: >-
  Scope, and how this entry relates to Wolfram_Syndrome. MONDO:0700293 is the gene-anchored
  concept covering everything heterozygous and biallelic WFS1 variants cause. It is curated
  as one disease with subtypes rather than as a grouping of separate diseases because the
  reference chapter is titled WFS1 Spectrum Disorder and opens by stating that WFS1-SD
  comprises classic and nonclassic forms: the field treats the allelic series as a single
  disorder.

  The consequence is a deliberate overlap with the existing Wolfram_Syndrome entry, which
  is bound to MONDO:0018105 and covers the recessive disease including the CISD2-related
  form. MONDO:0009101 Wolfram syndrome 1 is a subtype in both, and that is the only
  duplicated concept. Wolfram_Syndrome states in its own notes that it deliberately
  excludes the dominant arm and records it as a differential, so the two entries partition
  the work rather than competing: recessive mechanism, natural history, trials and
  treatment live there, and the dominant allele class, its three clinical forms and its
  separate mechanism live here. A reader wanting classic DIDMOAD should read
  Wolfram_Syndrome.

  Two neighbouring nonsyndromic hearing-loss entries are about different genes, not about
  WFS1: Autosomal_Dominant_Nonsyndromic_Hearing_Loss_11 is MYO7A and
  Autosomal_Recessive_Nonsyndromic_Hearing_Loss_35 is ESRRB. MYO7A belongs in this entry's
  differential, because DFNA11 is another cause of the ascending audiogram, and it is
  listed there.

  The committed deep-research report has a scope error, and anyone reusing it should know
  before they do. research/WFS1-Related_Disorder-deep-research-openscientist.md was asked
  about MONDO:0700293 and answered about classic recessive Wolfram syndrome: its summary
  opens by equating WFS1-related disorder with DIDMOAD, its phenotype table is the
  Washington University recessive
  natural-history cohort, and the dominant arm appears only as three passing mentions of a
  "wolframinopathy" spectrum. That is the Named Entity Confusion failure mode reached
  through a gene-anchored concept name, and most of what it produced duplicates the
  existing Wolfram_Syndrome entry rather than informing this one. One citation it surfaced
  was genuinely useful and is used here: PMID:36764396, the systematic review of 86
  Wolfram-like patients, which supplies the dominant arm's feature frequencies, its
  genotype-phenotype correlation and its survival statement. Nothing else in this entry
  rests on it.

  What is not here. There are no animal_models, computational_models, biochemical or
  clinical_trials blocks. A Wfs1E864K knock-in mouse exists and is cited under
  pathophysiology as evidence, but no publication cited here characterises it as a model of
  the human disease with the fidelity and limitations an AnimalModel record needs, so it is
  left as evidence rather than promoted to a model record. No trial of any intervention in
  nonclassic WFS1-SD was found; the sodium valproate trial that exists in this space
  (NCT03717909) enrolled classic Wolfram syndrome and is curated in the Wolfram_Syndrome
  entry, where it belongs.

  Subtype terms. Three of the four subtypes are MONDO descendants of MONDO:0700293:
  Wolfram syndrome 1, autosomal dominant nonsyndromic hearing loss 6, and Wolfram-like
  syndrome. The fourth, the neonatal diabetes-deafness-cataract syndrome, is bound to
  MONDO:0100072, which is the right concept by label but whose hierarchical ancestors do
  not include MONDO:0700293 - MONDO has not placed it under the gene-anchored term. It is
  curated as a subtype on the strength of the primary report rather than on the ontology's
  placement, and the discrepancy is recorded here rather than worked around.

  Hypotonia is the one phenotype here with no upstream node. It is reported in four of
  the five patients in the defining series and nothing in the cited literature says what
  produces it, so it is left unconnected rather than attached to the beta-cell or
  endoplasmic-reticulum nodes on a guess.

  GeneReviews lists two further nonclassic phenotypes - isolated diabetes mellitus and
  isolated congenital cataracts - that are not subtypes here. No source read for this entry
  characterises those presentations beyond naming them, so a subtype record would carry a
  term and a restatement of its own label and nothing else.

📚

References & Deep Research

References

13

PMID:20301750

WFS1 Spectrum Disorder.

No top-level findings curated for this source.

PMID:11709537

Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss.

No top-level findings curated for this source.

PMID:11709538

Non-syndromic progressive hearing loss DFNA38 is caused by heterozygous missense mutation in the Wolfram syndrome gene WFS1.

No top-level findings curated for this source.

PMID:21538838

Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment.

No top-level findings curated for this source.

PMID:28468959

Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts.

No top-level findings curated for this source.

PMID:36833385

Genotype and Phenotype Analyses of a Novel WFS1 Variant (c.2512C>T p.(Pro838Ser)) Associated with DFNA6/14/38.

No top-level findings curated for this source.

PMID:37121227

Monogenic Causes of Low-Frequency Non-Syndromic Hearing Loss.

No top-level findings curated for this source.

PMID:38651637

The Wolfram-like variant WFS1(E864K) destabilizes MAM and compromises autophagy and mitophagy in human and mice.

No top-level findings curated for this source.

PMID:39552476

The phenotypic spectrum of syndromic optic atrophy associated with variants in WFS1: with reclassification of p.Val606Gly as a likely benign variant.

No top-level findings curated for this source.

PMID:39858604

The Heterozygous p.A684V Variant in the WFS1 Gene Is a Mutational Hotspot Causing a Severe Hearing Loss Phenotype.

No top-level findings curated for this source.

PMID:12649740

The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells.

No top-level findings curated for this source.

PMID:41048689

Wolfram-like Syndrome: Shedding Light on a Variant of Wolfram Syndrome.

No top-level findings curated for this source.

PMID:36764396

Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum.

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (3)

Record notes

Scope, and how this entry relates to Wolfram_Syndrome. MONDO:0700293 is the gene-anchored concept covering everything heterozygous and biallelic WFS1 variants cause. It is curated as one disease with subtypes rather than as a grouping of separate diseases because the reference chapter is titled WFS1 Spectrum Disorder and opens by stating that WFS1-SD comprises classic and nonclassic forms: the field treats the allelic series as a single disorder. The consequence is a deliberate overlap with the existing Wolfram_Syndrome entry, which is bound to MONDO:0018105 and covers the recessive disease including the CISD2-related form. MONDO:0009101 Wolfram syndrome 1 is a subtype in both, and that is the only duplicated concept. Wolfram_Syndrome states in its own notes that it deliberately excludes the dominant arm and records it as a differential, so the two entries partition the work rather than competing: recessive mechanism, natural history, trials and treatment live there, and the dominant allele class, its three clinical forms and its separate mechanism live here. A reader wanting classic DIDMOAD should read Wolfram_Syndrome. Two neighbouring nonsyndromic hearing-loss entries are about different genes, not about WFS1: Autosomal_Dominant_Nonsyndromic_Hearing_Loss_11 is MYO7A and Autosomal_Recessive_Nonsyndromic_Hearing_Loss_35 is ESRRB. MYO7A belongs in this entry's differential, because DFNA11 is another cause of the ascending audiogram, and it is listed there. The committed deep-research report has a scope error, and anyone reusing it should know before they do. research/WFS1-Related_Disorder-deep-research-openscientist.md was asked about MONDO:0700293 and answered about classic recessive Wolfram syndrome: its summary opens by equating WFS1-related disorder with DIDMOAD, its phenotype table is the Washington University recessive natural-history cohort, and the dominant arm appears only as three passing mentions of a "wolframinopathy" spectrum. That is the Named Entity Confusion failure mode reached through a gene-anchored concept name, and most of what it produced duplicates the existing Wolfram_Syndrome entry rather than informing this one. One citation it surfaced was genuinely useful and is used here: PMID:36764396, the systematic review of 86 Wolfram-like patients, which supplies the dominant arm's feature frequencies, its genotype-phenotype correlation and its survival statement. Nothing else in this entry rests on it. What is not here. There are no animal_models, computational_models, biochemical or clinical_trials blocks. A Wfs1E864K knock-in mouse exists and is cited under pathophysiology as evidence, but no publication cited here characterises it as a model of the human disease with the fidelity and limitations an AnimalModel record needs, so it is left as evidence rather than promoted to a model record. No trial of any intervention in nonclassic WFS1-SD was found; the sodium valproate trial that exists in this space (NCT03717909) enrolled classic Wolfram syndrome and is curated in the Wolfram_Syndrome entry, where it belongs. Subtype terms. Three of the four subtypes are MONDO descendants of MONDO:0700293: Wolfram syndrome 1, autosomal dominant nonsyndromic hearing loss 6, and Wolfram-like syndrome. The fourth, the neonatal diabetes-deafness-cataract syndrome, is bound to MONDO:0100072, which is the right concept by label but whose hierarchical ancestors do not include MONDO:0700293 - MONDO has not placed it under the gene-anchored term. It is curated as a subtype on the strength of the primary report rather than on the ontology's placement, and the discrepancy is recorded here rather than worked around. Hypotonia is the one phenotype here with no upstream node. It is reported in four of the five patients in the defining series and nothing in the cited literature says what produces it, so it is left unconnected rather than attached to the beta-cell or endoplasmic-reticulum nodes on a guess. GeneReviews lists two further nonclassic phenotypes - isolated diabetes mellitus and isolated congenital cataracts - that are not subtypes here. No source read for this entry characterises those presentations beyond naming them, so a subtype record would carry a term and a restatement of its own label and nothing else.

Create: WFS1-Related Disorder · 2026-09-25T16:03:37Z · View source

De novo curation of MONDO:0700293, the WFS1 allelic series, closing the curation claim in issue #12794 and deleting stubs/WFS1-related_Disorder.yaml. Lump/split. Decided DISEASE with has_subtypes rather than GROUPING, from the literature rather than from the stub's descendant count. The GeneReviews chapter for this concept (PMID:20301750) is titled "WFS1 Spectrum Disorder" and states that WFS1-SD comprises classic and nonclassic forms, so the field treats the series as one disorder with subtypes. Four subtypes: Classic WFS1-SD (MONDO:0009101), DFNA6/14/38 (MONDO:0010963), Wolfram-like syndrome (MONDO:0013673), and the neonatal diabetes-deafness-cataract syndrome (MONDO:0100072). The first three are the descendants the stub recorded; the fourth is not a MONDO descendant of MONDO:0700293 - checked via the OLS hierarchicalAncestors endpoint, which returns only generic ancestors - and is carried on the strength of the primary report, with the discrepancy recorded in the entry's notes. Overlap with existing entries. Checked before writing. Wolfram_Syndrome (MONDO:0018105) already curates the recessive disease including the CISD2 form, and its own notes say it deliberately excludes the dominant arm and records it as a differential; this entry carries that arm. MONDO:0009101 is the only duplicated concept, appearing as a subtype in both. The two nonsyndromic hearing-loss entries the prompt flagged are unrelated: Autosomal_Dominant_Nonsyndromic_Hearing_Loss_11 is MYO7A and Autosomal_Recessive_Nonsyndromic_Hearing_Loss_35 is ESRRB, and each mentions WFS1 only inside a quoted sentence about candidate-gene exclusion or a control cohort. MYO7A is listed in this entry's differential because DFNA11 is another cause of the ascending audiogram. Deep research. The requested provider, falcon, returned HTTP 402 (Edison account out of credits). Rather than substituting by hand, the run was re-issued as `just dr_fallback='--fallback' research-disorder falcon WFS1-Related_Disorder`; openscientist produced the report, which records fell_back, requested_provider and provider_attempts in its frontmatter. Committed as research/WFS1-Related_Disorder-deep-research-openscientist.md with its citations sidecar and its two artifacts (final_report.html/pdf). The report has a scope error worth recording. Asked about MONDO:0700293 it answered about classic recessive Wolfram syndrome - its summary equates WFS1-related disorder with DIDMOAD, its phenotype table is the Washington University recessive natural-history cohort, and the dominant arm appears only in three passing mentions of a "wolframinopathy" spectrum. That is Named Entity Confusion reached through a gene-anchored concept name, and most of the report duplicates the existing Wolfram_Syndrome entry. One citation it surfaced was genuinely useful and is used: PMID:36764396, the 86-patient systematic review of Wolfram-like syndrome, which supplies the dominant arm's feature frequencies (optic atrophy 87%, hearing impairment 94%, diabetes 44%), its genotype-phenotype correlation, and its survival statement. Every other reference was found through PubMed E-utilities searches run directly. The report carried no reference-validation section when it landed, so `just validate-research-reference` was run on it: 33/33 references resolved, 14/14 quoted claims found in source, 0 off topic. Its pre-existing term-validation section lists five identifiers the report names as something else; none of them was used here, since every CURIE in this entry was read from cache/<prefix>/terms.csv or from an OLS lookup in the same step it was written. Evidence. 73 snippets across 13 references, all exact-quote verified against references_cache by `just count-verified-snippets` (73/73) and by `just validate-disorders`. Sources are the GeneReviews chapter, the two 2001 founding DFNA6/DFNA38 papers (PMID:11709537, PMID:11709538), the p.A684V optic-atrophy cohort (PMID:21538838) and the 14-patient Japanese p.A684V series (PMID:39858604), the dominant ER-stress neonatal-diabetes paper (PMID:28468959), the p.E864K MAM/mitophagy study (PMID:38651637), the mouse inner-ear wolframin localisation study (PMID:12649740), the DFNA6/14/38 family study (PMID:36833385), the Wolfram-like systematic review (PMID:36764396) and case report (PMID:41048689), the WFS1 optic-atrophy series (PMID:39552476), and the low-frequency hearing-loss review (PMID:37121227). Content types are abstract_only or full_text_xml throughout; no full_text_html snippet was used, given the stale cache-body problem in issue #12672. Two snippets had to be reshaped because the validator strips bracketed reference markers mid-quote; they were split at the bracket rather than edited. Mechanism. Ten pathophysiology nodes in a connected chain from the heterozygous exon 8 allele to four tissue-level outcomes, with mechanism_confidence set per node: ESTABLISHED for the aggregation/ER-stress and MAM/calcium nodes, PROVISIONAL for the reduced-protein and beta-cell nodes, HYPOTHETICAL for the proposed dominant-negative interference and for inner-ear ion homeostasis. genetic_context.functional_impact_category is UNKNOWN rather than DOMINANT_NEGATIVE: the literature offers dominant-negative interference and toxic gain of function as alternatives in the same paragraph and settles neither, so the two candidates are modelled as separate downstream nodes and the unresolved question is recorded as a discussion. Eight of the nine phenotypes are causally connected to a pathophysiology node; hypotonia is left ISOLATED because nothing in the cited literature says what produces it, and an edge added to clear a report would be worse than the gap. Two KNOWLEDGE_GAP discussions: why the non-syndromic form takes the low frequencies when wolframin shows no basal-to-apical cochlear expression gradient, and whether the dominant alleles interfere with wild-type protein or act by toxic gain of function. Not curated: animal_models, computational_models, biochemical, clinical_trials, datasets. The Wfs1E864K knock-in mouse is cited as evidence but no source characterises it as a model with the fidelity and limitations an AnimalModel record needs. No trial in nonclassic WFS1-SD was found; NCT03717909 enrolled classic disease and is curated in Wolfram_Syndrome. GeneReviews' isolated-diabetes and isolated-cataract nonclassic phenotypes are named in the entry's notes but not made subtypes, because no source read characterises them beyond the name. Validation run, all passing: just validate-disorders (schema, terms, references, 73 snippets, 0 issues), just count-verified-snippets (73/73), just validate-terms, just check-entity-refs, just check-causal-targets, just check-duplicate-keys, just check-enum-values, just check-coarse-phenotypes, just check-reference-titles, just check-genereviews (GeneReviews TAGGED, exact match to NBK4144), just list-gene-term-mismatches (6/6 bindings name the gene the entry names), just validate-stubs, just check-stubs, and pytest -k WFS1 (2 passed). references_cache/ and cache/ were checked after every validator run and reverted to any file this entry did not intend to change; PMID_20301750.md and PMID_27434582.md were each reverted once after a validator rewrote them, per issue #12672.

Self-review before the automated review landed · 2026-09-25T16:03:37Z · View source

Three corrections found by re-reading the committed entry, all pushed before the reviewer's verdict. The p.A684V hearing-loss phenotype was scoped to the Wolfram-like subtype and carried frequency FREQUENT. Both were wrong. In the fourteen-patient Japanese series that allele gave hearing loss and nothing else in most carriers - optic atrophy in two of eleven assessed, diabetes in none - so filing it under the syndromic subtype asserted a presentation those patients did not have, and a whole-entity frequency has no published denominator. The scoping and the frequency are removed and the reason is recorded in the phenotype's notes; the same overstatement in the entry description is corrected to say that the allele cuts across both presentations. Two evidence explanations described the "Alternatively, the aberrant protein has a toxic gain-of-function effect" sentence as though it were in the quote. It is not: the snippet validator strips the bracketed reference marker that separates it from the preceding sentence, so the quote had to be cut there. Both explanations now say where the alternative lives and why it is not quoted. The same node's genetic_context gained a note explaining why variant_origin is GERMLINE rather than DE_NOVO on a node that covers both transmitted and de novo alleles. The deep-research paragraph in notes: narrated the curation run rather than describing the artifact. Rewritten to lead with what a reader reusing the committed report needs to know - it was asked about MONDO:0700293 and answered about recessive Wolfram syndrome - leaving the provider-fallback history to the report's own frontmatter, per the rule that notes: is not a session log. Re-validated after each change: just validate-disorders (0 issues, 73 snippets) and just check-folded-hyphens, which caught one line-ending hyphen split introduced by the clinical_burden text and was fixed before commit.

OpenScientist ▸

WFS1-Related Disorder (Wolfram Syndrome / DIDMOAD): Comprehensive Disease Characteristics Report

openscientist-autonomous 33 citations 2026-09-25T15:59:36.372274

WFS1-Related Disorder (Wolfram Syndrome / DIDMOAD): Comprehensive Disease Characteristics Report

Disease: WFS1-Related Disorder (Wolfram syndrome type 1; DIDMOAD) MONDO ID: MONDO:0700293 · OMIM: #222300 · Category: Mendelian (monogenic) Report basis: 17 confirmed findings, 41 papers reviewed across 5 investigative iterations

Summary

WFS1-Related Disorder — clinically known as Wolfram syndrome or by the acronym DIDMOAD (Diabetes Insipidus, early-onset Diabetes Mellitus, Optic Atrophy, and Deafness) — is a rare, predominantly autosomal recessive, progressive neurodegenerative and neuro-endocrine disorder caused by loss-of-function variants in the WFS1 gene, which encodes the endoplasmic reticulum (ER) membrane protein wolframin. Wolframin regulates ER calcium homeostasis and the unfolded protein response (UPR); its loss produces chronic, unresolvable ER stress that drives apoptosis of highly secretory and metabolically demanding cell types. The result is a stereotyped but variable clinical sequence: childhood-onset, insulin-dependent, autoantibody-negative diabetes mellitus (~age 6), followed by optic atrophy, central diabetes insipidus (~age 10), and sensorineural hearing loss (~age 8), with later neurological, urological, and psychiatric involvement (PMID: 25764693; PMID: 23981289).

The disease mechanism is now well characterized as a coherent causal chain: biallelic WFS1 loss → chronic ER stress with activation of all three UPR arms (PERK, IRE1α/XBP1, ATF6) → inositol-1,4,5-trisphosphate receptor (IP3R)-mediated cytosolic Ca²⁺ dysregulation → mitochondrial dysfunction and impaired proinsulin processing → apoptosis of pancreatic β-cells, retinal ganglion cells, hypothalamic vasopressin neurons, and cochlear/brainstem neurons, with non-cell-autonomous oligodendroglial white-matter loss contributing to neurodegeneration (PMID: 27434582; PMID: 28271591; PMID: 41896889; PMID: 39198924).

Prognosis is poor: median age at death is approximately 39 years, most often from respiratory failure secondary to brainstem atrophy (PMID: 31337416). There is currently no disease-modifying therapy. Management is multidisciplinary and supportive — the ER-calcium stabilizer dantrolene was safe but ineffective in a phase Ib/IIa trial, and GLP-1 receptor agonists give glycemic benefit in some patients but no proven neuroprotection (PMID: 34185708; PMID: 42597412). The first international clinical consensus (Delphi) management guidelines were recently published (PMID: 42428113). The broader "wolframinopathy" spectrum includes a milder autosomal dominant Wolfram-like syndrome and allelic dominant deafness/optic atrophy, while a distinct Wolfram syndrome type 2 is caused by CISD2 and operates through mitochondrial iron/ROS toxicity (PMID: 36764396; PMID: 42339507).

1. Disease Information

Wolfram syndrome (WFS; OMIM #222300) is a rare recessive neuro-endocrine degenerative disorder, historically named DIDMOAD for its cardinal features: Diabetes Insipidus, early-onset Diabetes Mellitus, Optic Atrophy, and Deafness (PMID: 25764693). It is an ultra-rare, progressive neurodegenerative disease characterized by early-onset diabetes mellitus and irreversible loss of vision secondary to optic nerve degeneration (PMID: 37181110).

Key identifiers:

Resource	Identifier
MONDO	MONDO:0700293
OMIM	#222300 (Wolfram syndrome type 1)
Gene (WFS1)	OMIM *606201
Orphanet	ORPHA:3463 (Wolfram syndrome)
ICD-10	E13.x (other specified diabetes) with syndromic coding; cross-referenced to E23.2 (diabetes insipidus)
MeSH	D014929 (Wolfram Syndrome)

Synonyms / alternative names: DIDMOAD syndrome; Wolfram syndrome type 1 (WFS1); the "wolframinopathies" spectrum. Allelic dominant disorders include DFNA6/14/38 (low-frequency sensorineural hearing loss) and WFS1-related dominant optic atrophy.

Source type: The information here derives predominantly from aggregated disease-level resources (OMIM, Orphanet, systematic reviews, natural-history cohorts) and primary literature, supplemented by individual case reports illustrating diagnostic pathways. Cohort data (e.g., the Washington University natural-history study) provide individual-patient-derived aggregate statistics (PMID: 23981289).

2. Etiology

Primary cause — genetic. WFS1-Related Disorder is a purely monogenic disease. Classic Wolfram syndrome is caused by biallelic (recessive) loss-of-function variants in WFS1, encoding wolframin, an ER-embedded transmembrane protein functioning in ER calcium homeostasis and the unfolded protein response (PMID: 25764693). There is no environmental, lifestyle, toxic, or infectious cause — the disease is entirely genetically determined, though glycemic control and complication management modify morbidity (PMID: 31337416).

Genetic risk factors. Causal variants lie in WFS1 (chromosome 4p16.1). A distinct allelic gene, CISD2 (4q24), causes Wolfram syndrome type 2 (see Sections 4 and 15). Consanguinity and founder effects are the principal population-level risk amplifiers: a genetically confirmed Ecuadorian coastal cluster (Santa Elena) reported the highest local prevalence worldwide (~1/12,000), with ~50% consanguinity and 23/26 patients homozygous (PMID: 41998697).

Genetic modifiers. Genotype itself is the principal modifier of severity: variant type (in-frame vs out-of-frame/truncating) and location relative to transmembrane domains predict onset (PMID: 42524523).

Protective factors. No environmental protective factors are established. The primary "protective" genetic influence is milder variant class — in-frame variants outside transmembrane domains (notably the Ashkenazi Jewish founder allele c.1672C>T, p.Arg558Cys) produce a milder phenotype with later onset (PMID: 42524523).

Gene–environment interactions. No true gene–environment interactions are documented for disease causation. The dominant environmental modifier of outcome (not risk) is quality of glycemic control and multidisciplinary complication management.

3. Phenotypes

The phenotype spectrum has been quantified in a Washington University cross-sectional cohort (n=18, ages 5.9–25.8) and longitudinal audiology studies (PMID: 23981289; PMID: 29945639).

Phenotype	Suggested HPO	Type	Frequency	Mean age of onset	Progression
Diabetes mellitus (insulin-dependent, autoantibody-negative)	HP:0000819	Lab/endocrine	~94%	6.3 ± 3.5 yr	Progressive, lifelong
Optic atrophy / disc pallor, color-vision defect	HP:0000648	Clinical sign	~94%	Childhood	Progressive
Central diabetes insipidus	HP:0000873	Endocrine	~72%	10.6 ± 3.3 yr	Progressive
Sensorineural hearing loss	HP:0000407	Clinical sign	~75–78%	8.3 ± 5.1 yr	Progressive (high-frequency first)
Olfactory defect	HP:0000458	Sensory	~72%	Variable	Progressive
Impaired vibration sensation (peripheral neuropathy)	HP:0002495	Neurological	~44%	Variable	Progressive
Neurogenic bladder / elevated post-void residual	HP:0000011	Urologic	~45% (of tested)	Adolescence+	Progressive
Enuresis	HP:0000805	Urologic	~22%	Childhood	Variable
Psychiatric features (depression, anxiety)	HP:0000708	Behavioral	Common	Variable	Fluctuating
Brainstem atrophy / neurodegeneration	HP:0002508	Neurological	Late	Adult	Progressive (life-limiting)

Quantitative evidence: "Seventeen (94%) had diabetes mellitus with the average age of diabetes onset of 6.3 ± 3.5 years. Diabetes insipidus was diagnosed in 13 (72%) at an average age of 10.6 ± 3.3 years. Seventeen (94%) had optic disc pallor and defects in color vision, 14 (78%) had hearing loss and 13 (72%) had olfactory defects, eight (44%) had impaired vibration sensation" (PMID: 23981289). Longitudinal audiology (n=40): "Mean age of diagnosis for SNHL was 8.3 years (SD = 5.1) with 75% prevalence. HFA worsened over time for both ears" (PMID: 29945639).

Quality-of-life impact. Progressive, irreversible vision and hearing loss, insulin-dependent diabetes, and neurogenic bladder impose severe cumulative disability. Psychiatric morbidity and, in advanced disease, brainstem-mediated bulbar/respiratory dysfunction dominate late quality of life. Formal per-phenotype QOL instrument data (EQ-5D/SF-36) are limited in this ultra-rare disease.

4. Genetic / Molecular Information

Causal genes. - WFS1 (HGNC:12762; OMIM 606201; chromosome 4p16.1) — encodes wolframin, an 890-amino-acid ER transmembrane glycoprotein. Cause of Wolfram syndrome type 1 (OMIM #222300). - CISD2 (HGNC:24212; OMIM 611507; chromosome 4q24) — cause of Wolfram syndrome type 2 (WFS2; OMIM #604928).

Pathogenic variant landscape. Variant types span the full loss-of-function spectrum: missense, nonsense, frameshift (out-of-frame indels), and splice-site variants. Classification follows ACMG/AMP guidelines (pathogenic, likely pathogenic, VUS). A representative novel VUS — heterozygous WFS1 c.1550G>C (p.Arg517Pro) — was classified using PM2_Supporting (allele frequency 0.000077) and PP3_Moderate (REVEL deleterious prediction) (PMID: 41613956).

Genotype–phenotype / severity correlation. A severity scoring system based on variant type (in-frame vs out-of-frame) and location relative to transmembrane domains (six severity classes) was applied to 324 patients: score correlated with earlier onset of diabetes mellitus and, less consistently, optic atrophy, but not hearing loss or central DI. "Patients with in-frame variants outside transmembrane domains showed milder disease, especially the WFS1 c.1672C>T (p.Arg558Cys) variant... whereas out-of-frame variants showed the earliest onset" (PMID: 42524523). Consistently, the systematic review of dominant Wolfram-like syndrome found "Patients with missense mutations in WFS1 had a lower number of clinical manifestations, less chance of developing diabetes insipidus, but a younger age at onset of hearing impairment compared to patients with nonsense mutations or deletions causing frameshift" (PMID: 36764396).

Functional consequences. Recessive WFS1 variants are loss of function (reduced/absent functional wolframin → ER stress). Certain heterozygous dominant WFS1 variants act via dominant-negative or gain-of-toxic-function mechanisms producing constitutive ER stress: "A novel heterozygous mutation of the WFS1 gene leading to constitutive endoplasmic reticulum stress is the cause of Wolfram syndrome" (PMID: 28271591).

Origin. Germline; no somatic/oncologic role in the Mendelian disorder (a separate literature implicates WFS1 as a transcriptional hub in prostate cancer, unrelated to the inherited syndrome — PMID: 40345286).

Allele frequency. Pathogenic WFS1 variants are individually rare (e.g., p.Arg517Pro at 0.000077 in gnomAD); founder alleles are regionally enriched (Ashkenazi p.Arg558Cys; Ecuadorian exon-8 variants; Palestinian CISD2 c.109G>C with carrier rate 1:40) (PMID: 41613956; PMID: 41998697; PMID: 42339507).

Modifier genes / epigenetics / chromosomal abnormalities. No specific modifier genes beyond the primary genotype are established. No epigenetic mechanism or large-scale chromosomal abnormality is characterized as causal; the disease is driven by point mutations and small indels in WFS1/CISD2.

5. Environmental Information

Not applicable as a cause. WFS1-Related Disorder has no environmental, toxic, radiation, occupational, lifestyle, or infectious etiology. The disease is entirely genetic (PMID: 31337416). Environmental factors influence only the management/outcome dimension — chiefly glycemic control, which modifies diabetic complication burden but does not alter the underlying neurodegenerative trajectory.

6. Mechanism / Pathophysiology

Ordered causal chain

Biallelic loss-of-function WFS1 variants reduce or abolish functional wolframin, an ER-membrane protein → loss of ER calcium homeostasis and UPR regulation (PMID: 25764693).
Wolframin deficiency → chronic, unresolvable ER stress, because WFS1 is itself a UPR component; "Because WFS1 is a UPR component, mutant WFS1 might cause unresolvable ER stress conditions and cell apoptosis, the major causes underlying WS symptoms" (PMID: 28271591).
ER stress activates all three UPR arms — PERK (↑p-PERK, ATF4), IRE1α (↑XBP1s, phospho-IRE1α), and ATF6 (PMID: 41896889).
ER stress → IP3R dysfunction → disturbed cytosolic Ca²⁺ homeostasis, which "in turn, alters mitochondrial dynamics" (inhibited fusion, altered trafficking, augmented mitophagy) → delayed neuronal development (PMID: 27434582).
In parallel, ER stress impairs proinsulin-to-insulin processing, with accumulation of proinsulin and an increased proinsulin/insulin ratio → β-cell secretory failure (PMID: 41896889).
Combined ER-stress, Ca²⁺, and mitochondrial insults → apoptosis of high-secretory / high-metabolic cells: pancreatic β-cells, retinal ganglion cells, hypothalamic arginine-vasopressin (AVP) neurons, cochlear and brainstem neurons (PMID: 16215705; PMID: 35452662).
Branch — non-cell-autonomous injury: white-matter/myelin loss implicates oligodendroglia in optic neuropathy and brain neurodegeneration, indicating the process is not purely neuron-autonomous (PMID: 39198924).
Cumulative cell loss → clinical DIDMOAD (β-cell loss → DM; RGC/optic nerve loss → optic atrophy; AVP neuron loss → central DI; cochlear loss → SNHL) → progressive neurodegeneration → brainstem atrophy → respiratory failure → death (~39 yr) (PMID: 31337416).

Detail by category

Molecular pathways: Unfolded protein response (PERK–eIF2α–ATF4, IRE1α–XBP1, ATF6). ER Ca²⁺ signaling via IP3R and ryanodine receptors. Suggested GO terms: GO:0030968 (ER unfolded protein response); GO:0006816 (calcium ion transport); GO:0034976 (response to endoplasmic reticulum stress).
Cellular processes: Apoptosis (GO:0006915), autophagy/mitophagy (GO:0000422), impaired mitochondrial fusion/dynamics (GO:0008053), impaired regulated secretion.
Protein dysfunction: Loss of function of wolframin (recessive) or dominant-negative constitutive ER stress (some heterozygous variants). Wolframin also localizes to insulin secretory granules and contributes to intragranular acidification.
Metabolic changes: Impaired glucose-stimulated insulin secretion; accumulated proinsulin; energy-metabolism compromise from mitochondrial dysfunction.
Immune system: Not autoimmune — diabetes is autoantibody-negative. However, elevated inflammatory cytokines (IFN-γ, IL-1β, TNF-α) and the oxidative-stress marker isoprostane were observed in trial subjects, suggesting a secondary inflammatory/oxidative component (PMID: 34185708).
Tissue damage: Oxidative stress and apoptosis; in WFS2, mitochondrial iron overload and ROS toxicity (PMID: 42339507).
Subcellular compartments: ER (GO:0005783), mitochondria (GO:0005739), secretory granules.
Cell types (CL): pancreatic β-cell (CL:0000169), retinal ganglion cell (CL:0000740), oligodendrocyte (CL:0000128), neuron (CL:0000540).

Upstream vs downstream

Upstream: WFS1 mutation → wolframin loss → ER stress. Midstream: UPR activation, IP3R/Ca²⁺ dysregulation, mitochondrial dysfunction, impaired proinsulin processing. Downstream: apoptosis of target cells → organ-specific clinical manifestations → brainstem neurodegeneration.

WFS1 LoF ─► wolframin loss ─► chronic ER stress ─► UPR (PERK/IRE1α/ATF6)
                     │                     │
                     ▼                     ▼
        IP3R ─► cytosolic Ca2+↑    impaired proinsulin
                     │              processing (β-cell)
                     ▼                     │
        mitochondrial dysfunction ◄────────┘
                     │
                     ▼
 APOPTOSIS: β-cells, RGCs, AVP neurons, cochlear/brainstem
     + oligodendroglial white-matter loss (branch)
                     │
                     ▼
DM(~6yr) ─ Optic atrophy ─ DI(~10yr) ─ SNHL(~8yr) ─► brainstem
                                atrophy ─► respiratory failure (~39yr)

7. Anatomical Structures Affected

Level	Structure	Ontology	Evidence
Organ	Endocrine pancreas (islets)	UBERON:0000006	β-cell loss → DM (PMID: 16215705)
Organ	Optic nerve	UBERON:0000941	Optic atrophy, RGC loss (PMID: 35452662)
Organ	Hypothalamus (AVP neurons)	UBERON:0001898	Central DI (PMID: 23981289)
Organ	Cochlea / inner ear	UBERON:0001844	SNHL (PMID: 29945639)
Organ	Brainstem	UBERON:0002298	Atrophy → respiratory failure (PMID: 31337416)
Organ (secondary)	Urinary bladder	UBERON:0001255	Neurogenic bladder (PMID: 23981289)
Tissue	CNS white matter / myelin	UBERON:0002316	Demyelinating lesions, oligodendroglial loss (PMID: 39198924; PMID: 41245872)
Cell	Pancreatic β-cell	CL:0000169	ER-stress apoptosis
Cell	Retinal ganglion cell	CL:0000740	Distinct-from-mitochondrial loss pattern
Cell	Oligodendrocyte	CL:0000128	White-matter contribution
Subcellular	Endoplasmic reticulum	GO:0005783	Primary site of wolframin action
Subcellular	Mitochondria	GO:0005739	Altered dynamics, downstream dysfunction

Body systems: endocrine, nervous (central + autonomic + sensory), special sensory (visual, auditory, olfactory), genitourinary. Lateralization: manifestations are characteristically bilateral (bilateral optic atrophy, bilateral SNHL).

8. Temporal Development

Onset: pediatric/childhood, insidious and progressive. Diabetes mellitus is typically the first manifestation (~age 6), followed over years by optic atrophy, central DI (~age 10), and SNHL (~age 8) (PMID: 23981289).

Progression: chronically progressive across all domains — high-frequency hearing worsens over time with greater decline in younger patients (PMID: 29945639); visual acuity declines steadily (PMID: 42597412). No remission occurs; the course is monotonic and life-limiting.

Stages: (early) childhood diabetes + emerging optic atrophy → (intermediate) DI, SNHL, urologic and neurologic involvement → (advanced/end-stage) brainstem atrophy, bulbar/respiratory compromise.

Disease duration: chronic, lifelong. Critical intervention window: the early-childhood period around/before β-cell and neuronal loss is the presumed therapeutic window for ER-stress-modulating or regenerative approaches (inferred from mechanism; not yet clinically validated).

9. Inheritance and Population

Epidemiology. Ultra-rare. Commonly cited prevalence estimates are on the order of 1/500,000–1/770,000 in outbred populations; consanguineous founder clusters reach far higher local prevalence — a genetically confirmed Ecuadorian coastal cluster reported ~1/12,000, the highest worldwide, with WFS1 positive in 26 (69%) patients and 23 homozygous (PMID: 41998697). In a Pan-India monogenic diabetes study, Wolfram syndrome (n=15) was the most common syndromic form among youth-onset monogenic diabetes (PMID: 40466744).

Inheritance pattern. Predominantly autosomal recessive (biallelic WFS1 or CISD2). "The transmission of the disease takes place in an autosomal recessive mode but autosomal dominant mutations responsible for WS-related disorders have been described" (PMID: 31337416). A milder autosomal dominant Wolfram-like spectrum exists — "autosomal dominantly inherited WFLS has a relatively mild phenotype compared to autosomal recessive WS" (PMID: 36764396).

Penetrance / expressivity. High/near-complete penetrance for the recessive form but highly variable expressivity — variable organ involvement and onset ages even within families. Anticipation: not a feature (not a repeat-expansion disorder). Founder effects / consanguinity: major drivers of regional prevalence (Ecuadorian exon-8 variants; Ashkenazi p.Arg558Cys; Palestinian CISD2 c.109G>C, carrier rate 1:40) (PMID: 41998697; PMID: 42339507; PMID: 42524523).

Demographics. No strong sex predilection reported for classic recessive WFS. Enriched in populations with high consanguinity. Age distribution skews pediatric-onset with adult progression.

10. Diagnostics

Clinical diagnosis rests on the DM + optic atrophy dyad, classically coexisting juvenile-onset diabetes mellitus and optic atrophy, confirmed molecularly (PMID: 41411089). Recognition of bilateral optic atrophy in an autoantibody-negative diabetic child prompts genetic testing: "Identifying the presence of bilateral optic atrophy in him during an ophthalmological evaluation led to a closer clinical assessment for Wolfram syndrome" (PMID: 42392675). Central diabetes insipidus (AVP deficiency) can serve as an early symptom-based screening indicator (PMID: 41080637).

Laboratory features: early-onset, insulin-dependent, pancreatic-autoantibody-negative diabetes (distinguishes from autoimmune type 1); water-deprivation testing / low copeptin for central DI; audiometry (high-frequency SNHL first).

Imaging: MRI shows brainstem/cerebellar atrophy and white-matter abnormalities, including progressive, seemingly inflammatory demyelinating lesions in a subset (7/17; 41% with ≥1 MS-evocative lesion) (PMID: 41245872). OCT shows RNFL/ganglion-cell-layer thinning with a pattern distinct from mitochondrial optic neuropathies (PMID: 35452662).

Genetic testing (confirmatory). Biallelic WFS1 variants on next-generation/whole-exome sequencing establish diagnosis; single-gene WFS1 testing, targeted panels (monogenic diabetes / optic atrophy / hearing loss panels), WES, and WGS are all applicable. CISD2 testing for WFS2.

Biomarkers. Serum/plasma neurofilament light chain (NfL) is elevated, reflecting ongoing slow neurodegeneration, though it does not correlate with current clinical/neuroimaging metrics and has limited utility as a progression monitor (PMID: 35495027; PMID: 41929703). Pancreatic stone protein/regenerating protein (PSP/reg) is a candidate circulating marker of ER-stressed β-cells: "PSP/reg levels are elevated in cell culture and mouse models of Wolfram syndrome, a prototype of ER stress-induced diabetes" (PMID: 30914711). Brain metabolites and mitochondrial DNA copy number are under investigation (PMID: 42042926).

Differential diagnosis: type 1 diabetes (autoimmune, autoantibody-positive); genetic optic neuropathies — OPA1-related dominant optic atrophy, Leber hereditary optic neuropathy (LHON), POLG-related optic neuropathy ("mutations in OPA1 (n=9), WFS1 (n=7), POLG (n=3)... LHON (n=17)") (PMID: 41411089); other monogenic/syndromic diabetes (MODY, mitochondrial MIDD).

Screening: cascade genetic testing of relatives; carrier screening in founder populations; consider WFS1 in the genetic evaluation of autoantibody-negative early-onset diabetes even without full syndromic features (PMID: 41613956).

11. Outcome / Prognosis

Prognosis is poor and life-limiting. "Prognosis is poor, death occurs at the median age of 39 years with a major cause represented by respiratory failure as a consequence of brain stem atrophy and neurodegeneration" (PMID: 31337416).

Morbidity/disability: progressive blindness, deafness, insulin-dependent diabetes, neurogenic bladder, peripheral neuropathy, and neuropsychiatric burden accumulate to severe multi-domain disability. Complications: diabetic complications, recurrent urinary tract infections (neurogenic bladder), aspiration and respiratory compromise from bulbar/brainstem involvement.

Prognostic factors: genotype (out-of-frame/truncating variants → earliest onset, presumptively worse trajectory; in-frame extramembrane variants → milder course) (PMID: 42524523). Prompt diagnosis and multidisciplinary management decrease morbidity/mortality via prevention/treatment of complications (PMID: 31337416). Candidate prognostic biomarkers (NfL, PSP/reg) remain investigational.

12. Treatment

No disease-modifying therapy exists. "There is currently no treatment to delay, halt, or reverse the progression of Wolfram syndrome, raising the urgency for innovative therapeutics for this disease" (PMID: 31420094). Care is multidisciplinary and supportive, now guided by the first international consensus: all 35 Delphi statements reached ≥80% agreement across diagnosis/genetics, neuro-ophthalmology, neurology, endocrinology, urology, gastroenterology, and psychiatry (PMID: 42428113).

Pharmacotherapy / supportive (NCIT-suggested): - Insulin (NCIT:C2271) — all WFS patients with DM require insulin. - Desmopressin/DDAVP for central diabetes insipidus. - Hearing aids / cochlear implants; low-vision rehabilitation; bladder management (intermittent catheterization, anticholinergics); psychiatric care.

GLP-1 receptor agonists (NCIT:C98005 class): improve glycemia in some patients (a New Zealand cohort reported HbA1c fall and insulin-dose reduction — PMID: 42324630), but the largest evaluation (n=84; 35.7% on GLP-1 RA) found "No statistically significant changes in HbA1c or body mass index... at one or two years. Best-corrected visual acuity (LogMAR) declined significantly at two years, consistent with expected disease progression" — i.e., no proven neuroprotective/visual benefit, with GI adverse effects in 56.7% (PMID: 42597412; PMID: 41959758).

Experimental / disease-modifying (investigational): - Dantrolene sodium (ryanodine-receptor/ER-Ca²⁺ stabilizer): first-ever Wolfram interventional trial (phase Ib/IIa, open-label). "Dantrolene sodium was well tolerated by Wolfram syndrome patients. Overall, β cell functions were not significantly improved"; visual and neurological functions were not improved at 6 months (PMID: 34185708). - Pipeline strategies under development: ER-homeostasis/chemical-chaperone modulators, gene therapy, and regenerative/β-cell replacement approaches (PMID: 37181110; PMID: 31420094).

Pharmacogenomics / personalized medicine: genotype-guided prognostication (severity scoring) is emerging; no established pharmacogenomic dosing rules.

13. Prevention

There is no primary prevention for this monogenic disease other than reproductive genetic counseling. Key measures:

Genetic counseling (autosomal recessive; 25% recurrence risk for carrier couples), especially important in consanguineous and founder populations (PMID: 31337416).
Carrier screening in founder populations (e.g., Ashkenazi p.Arg558Cys; Palestinian CISD2).
Prenatal / preimplantation genetic testing available once familial variants are known.
Cascade genetic testing of at-risk relatives.
Secondary prevention (early detection): consider WFS1 in autoantibody-negative early-onset diabetes; symptom-based screening using DI as an early indicator (PMID: 41080637; PMID: 41613956).
Tertiary prevention: multidisciplinary management to prevent/treat complications and reduce morbidity/mortality (PMID: 42428113).

Immunization and public-health/environmental interventions are not applicable (non-infectious, non-environmental).

14. Other Species / Natural Disease

Taxonomy / orthologs: WFS1 is conserved across mammals; mouse Wfs1 (NCBI Gene 22393) and rat orthologs exist, plus zebrafish orthologs used in modeling. CISD2 (WFS2) is likewise conserved.
Natural disease: No well-characterized naturally occurring companion-animal Wolfram syndrome analog is established in the reviewed literature; the disease is studied primarily through engineered models rather than spontaneous animal disease.
Comparative biology: Rodent Wfs1 models recapitulate ER-stress-driven β-cell apoptosis and diabetes and white-matter/RGC phenotypes, supporting evolutionary conservation of the disease mechanism (PMID: 16215705; PMID: 39198924).
Transmission: Not applicable (genetic, non-zoonotic).

15. Model Organisms

Model	Type	Key phenotype recapitulation	Evidence
β-cell-conditional Wfs1 KO mouse (RIP2-Cre; floxed exon 8)	Mammalian, conditional KO	Progressive glucose intolerance & insulin deficiency by ~12 wk; ↓β-cell mass, ↑apoptosis, ↑BiP, dilated ER, fewer secretory granules	PMID: 16215705
Wfs1-knockdown MIN6 insulinoma line	In vitro cellular	↑apoptosis, ↑BiP and CHOP (UPR/ER-stress markers)	PMID: 16215705
Mutant-WFS1-transfected MIN6	In vitro cellular	↑p-PERK, XBP1s, ATF4, pIRE1α; proinsulin accumulation, ↑proinsulin/insulin ratio	PMID: 41896889
Whole-body Wfs1 rodent & patient iPSC-derived models	Mammalian / cellular	White-matter/oligodendroglial and retinal-ganglion-cell phenotypes; optic neuropathy/neurodegeneration	PMID: 39198924
β-cell-specific Cisd2 KO mouse (WFS2 model)	Mammalian, conditional KO	Impaired insulin secretion, disrupted Ca²⁺ handling	PMID: 40189101
WFS2 patient fibroblasts	In vitro cellular	↑mitochondrial labile iron (+25%), ↑mitochondrial ROS (+28%); ER/mito damage partially reversible with deferiprone + N-acetylcysteine	PMID: 42339507

Documented evidence: "Analysis of islets from betaWfs(-/-) mice revealed a reduction in beta cell mass, enhanced apoptosis, elevation of a marker of endoplasmic reticulum stress (immunoglobulin heavy chain-binding protein [BiP]), and dilated endoplasmic reticulum with decreased secretory granules by electron microscopy" and "WfsKD cell lines had significantly increased apoptosis and elevated expression of the genes encoding BiP and C/EBP-homologous protein (CHOP)" (PMID: 16215705).

Recapitulation & limitations: Mouse and cellular Wfs1 models faithfully reproduce ER-stress-driven β-cell failure and key neurodegenerative features (RGC/white-matter), making them strong platforms for β-cell and optic-neuropathy studies. Limitations include incomplete modeling of the full human multi-system temporal sequence and of the late brainstem/respiratory endpoint. iPSC-derived neurons/organoids enable patient-specific, human-context study of neurodegeneration.

Wolfram syndrome type 2 (CISD2/WFS2) — a distinct allelic disease. WFS2 is caused by recessive CISD2 mutations and operates through mitochondrial iron and ROS toxicity rather than the primary ER-stress/UPR mechanism of WFS1: "Patient fibroblasts exhibited profound mitochondrial and endoplasmic reticulum damage, with increased mLI (+25%, p < 0.0001) and mROS (+28%, p < 0.0001)" (PMID: 42339507). WFS2 features "childhood-onset, autoantibody-negativity and insulin-deficiency" diabetes (PMID: 40189101) plus GI bleeding, platelet dysfunction, psychiatric morbidity, and congenital heart defects; a Palestinian founder mutation (CISD2 c.109G>C, carrier rate 1:40) exemplifies its founder epidemiology.

Mechanistic Model / Interpretation

The 17 confirmed findings converge on a single, internally consistent model of an ER-stress neurodegenerative/neuro-endocrine disease. The unifying logic is that wolframin normally buffers ER calcium and resolves the UPR; without it, the cells with the greatest secretory/metabolic ER load — insulin-secreting β-cells, AVP-secreting hypothalamic neurons, and high-firing/high-metabolic retinal ganglion, cochlear, and brainstem neurons — cannot cope with chronic ER stress and die by apoptosis. This elegantly explains the otherwise disparate DIDMOAD tetrad as tissue-specific readouts of a shared subcellular lesion. The oligodendroglial/white-matter branch adds a non-cell-autonomous dimension that helps account for the broader neurodegenerative and MRI findings.

The genotype–severity data (PMID: 42524523) reinforce a dose-of-function model: truncating variants abolishing wolframin cause the earliest, most severe disease, whereas in-frame variants that preserve partial function (Ashkenazi p.Arg558Cys) are milder. The therapeutic corollary — and the field's central challenge — is that by the time of diagnosis, irreversible cell loss has occurred, and both dantrolene (ER-Ca²⁺ stabilization) and GLP-1 RAs (β-cell support) have failed to alter the neurodegenerative trajectory. This motivates earlier intervention windows and mechanistically upstream strategies (chaperones, gene therapy, regenerative β-cell approaches).

Evidence Base — Key Literature

PMID	Contribution	Type
25764693	Defines disorder, DIDMOAD, OMIM 222300, recessive WFS1, wolframin ER function	Review
37181110	Ultra-rare progressive neurodegeneration; pathophysiology & therapeutic strategies	Review
27434582	ER stress → IP3R/Ca²⁺ → mitochondrial dynamics causal chain	In vitro/model
28271591	Constitutive ER stress & apoptosis from mutant WFS1	In vitro
41896889	Multi-arm UPR activation + impaired proinsulin processing; isolated diabetes	In vitro/clinical
36764396	Dominant Wolfram-like spectrum; phenotype frequencies; genotype-phenotype	Systematic review (n=86)
41998697	Ecuadorian founder cluster; recessive/consanguineous epidemiology	Cohort
23981289	Phenotype frequencies & ages of onset	Natural-history cohort
29945639	Longitudinal SNHL prevalence/progression	Natural-history cohort
42524523	Genotype-based severity scoring (n=324); Ashkenazi allele	Cohort
42597412	GLP-1 RA: no glycemic/visual benefit (largest cohort)	Cohort
42428113	First international Delphi consensus management guidelines	Consensus
42339507	WFS2/CISD2 mitochondrial iron/ROS toxicity	Cohort/in vitro
40189101	CISD2 Ca²⁺ handling; WFS2 diabetes	Model
31337416	Prognosis (median death ~39 yr, respiratory failure); AR inheritance	Review
35452662	RGC loss pattern distinct from mitochondrial optic neuropathies	Clinical
39198924	Oligodendroglial/white-matter role	Mouse+iPSC
16215705	β-cell-conditional KO mouse & MIN6 knockdown models	Model/in vitro
35495027 / 41929703	Elevated NfL biomarker (limited monitoring utility)	Clinical
30914711	PSP/reg ER-stress β-cell biomarker	Model/in vitro
34185708	Dantrolene phase Ib/IIa: safe but ineffective	Clinical trial
31420094	No disease-modifying therapy; treatment landscape	Review
41411089	Optic-atrophy genetic differential (OPA1/POLG/LHON)	Case-control
42392675	Diagnostic dyad triggering genetic testing	Case report
41245872	Expanded white-matter/demyelinating MRI spectrum	Retrospective
40466744	WFS most common syndromic monogenic diabetes (Pan-India)	Cohort

Limitations and Knowledge Gaps

Ultra-rarity limits cohort size and statistical power. Most phenotype-frequency figures derive from single-center cohorts (n≈18–40); confidence intervals are wide and generalizability across ancestries is uncertain.
Prevalence estimates are imprecise and heavily influenced by founder/consanguineous clusters; true global incidence remains poorly quantified.
Biomarker validation incomplete. NfL is elevated but does not correlate with clinical/imaging metrics, limiting its use as a progression monitor; PSP/reg data are largely preclinical. Robust surrogate endpoints for trials are lacking.
Mechanistic gaps in cell-type selectivity. Why specific neuronal populations (RGC, AVP, brainstem) and β-cells are preferentially vulnerable is not fully explained beyond secretory/metabolic load; the oligodendroglial contribution is newly recognized and incompletely mapped.
No effective therapy. Two rational strategies (dantrolene; GLP-1 RAs) failed to modify neurodegeneration, and the therapeutic window/optimal intervention timing is undefined.
Quality-of-life and long-term natural-history data are sparse, particularly per-phenotype QOL instruments and adult/end-stage trajectories.
Modifier genetics beyond primary genotype and any epigenetic contributions are essentially unstudied.

Proposed Follow-up Experiments / Actions

Prospective multinational natural-history registry with harmonized OCT, audiometry, MRI (including white-matter/demyelination protocols), and serial NfL/PSP-reg to define progression rates and validate surrogate endpoints.
Trial-ready biomarker qualification: longitudinal NfL, PSP/reg, brain metabolites, and mtDNA copy number as treatment-response markers; test whether combined panels correlate with imaging progression.
Earlier-window interventional trials: ER chaperones/UPR modulators (e.g., chemical chaperones), and WFS1 gene therapy / gene editing, initiated before substantial cell loss (childhood), using genotype (severity score) for stratification.
Regenerative/β-cell approaches: iPSC-derived, gene-corrected β-cell or neuron transplantation studies to test cell replacement in the ER-stress context.
Mechanistic dissection of oligodendroglial vulnerability using patient iPSC-derived oligodendrocyte and organoid co-culture models to test whether myelin protection slows optic/CNS neurodegeneration.
WFS2-specific translation: evaluate iron chelation (deferiprone) + antioxidant (N-acetylcysteine) combinations clinically, given partial reversibility of mitochondrial iron/ROS toxicity in fibroblasts.
Expand carrier/cascade screening in founder populations and integrate WFS1 into monogenic-diabetes and optic-atrophy gene panels to improve early diagnosis and counseling.

Report compiled from 17 confirmed findings and 41 reviewed papers over 5 investigative iterations. Evidence types span human clinical cohorts, model organism (mouse/iPSC) studies, in vitro experiments, and systematic reviews, as annotated throughout.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.3.0rc1.

Outcome	Count
References checked	33
Resolved	33
Unresolved (possible confabulation)	0
Unverifiable	0
Quoted claims checked	14
Quoted claims found in source	14
Quoted claims not found in source	0
References weighed for topical relevance	33
On topic	28
Off topic	0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	35
Resolved	32
Unresolved (possible confabulation)	0
Obsolete	0
Unverifiable	3
Terms whose name was checked	24
Terms named correctly	8
Terms named as a different term	5
Terms whose name is worth a second look	11

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

MONDO:0700293 (2 mentions) - the report calls it "MONDO"; MONDO calls it WFS1-related disorder
HP:0000819 (1 mention) - the report calls it "Diabetes mellitus (insulin-dependent, autoantibody-negative)"; HP calls it Diabetes mellitus
HP:0000648 (1 mention) - the report calls it "Optic atrophy / disc pallor, color-vision defect"; HP calls it Optic atrophy
HP:0000458 (1 mention) - the report calls it "Olfactory defect"; HP calls it Anosmia
HP:0002508 (1 mention) - the report calls it "Brainstem atrophy / neurodegeneration"; HP calls it Brainstem dysplasia

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

HP:0000873 (1 mention) - the report calls it "Central diabetes insipidus"; HP calls it Diabetes insipidus
HP:0002495 (1 mention) - the report calls it "Impaired vibration sensation (peripheral neuropathy)"; HP calls it Impaired vibratory sensation
HP:0000011 (1 mention) - the report calls it "Neurogenic bladder / elevated post-void residual"; HP calls it Neurogenic bladder
HP:0000708 (1 mention) - the report calls it "Psychiatric features (depression, anxiety)"; HP calls it Atypical behavior, and lists "Psychiatric disorders" among its other names
GO:0005739 (2 mentions) - the report calls it "Mitochondria"; GO calls it mitochondrion, and lists "mitochondria" among its other names
CL:0000169 (2 mentions) - the report calls it "Pancreatic β-cell"; CL calls it type B pancreatic cell, and lists "pancreatic B-cell" among its other names
UBERON:0000006 (1 mention) - the report calls it "Endocrine pancreas (islets)"; UBERON calls it islet of Langerhans, and lists "pancreatic islet" among its other names
UBERON:0000941 (1 mention) - the report calls it "Optic nerve"; UBERON calls it cranial nerve II, and lists "optic nerve" among its other names
UBERON:0001898 (1 mention) - the report calls it "Hypothalamus (AVP neurons)"; UBERON calls it hypothalamus
UBERON:0001844 (1 mention) - the report calls it "Cochlea / inner ear"; UBERON calls it cochlea, and lists "cochlear organ" among its other names
UBERON:0002316 (1 mention) - the report calls it "CNS white matter / myelin"; UBERON calls it white matter, and lists "CNS white matter" among its other names

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA.

Ask OpenScientist

OpenScientist Report

Inheritance

Subtypes

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Prevalence

Clinical Burden

Differential Diagnoses

Source YAML

References & Deep Research

References

Deep Research

WFS1-Related Disorder (Wolfram Syndrome / DIDMOAD): Comprehensive Disease Characteristics Report

Summary

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic / Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

Ordered causal chain

Detail by category

Upstream vs downstream

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome / Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Mechanistic Model / Interpretation

Evidence Base — Key Literature

Limitations and Knowledge Gaps

Proposed Follow-up Experiments / Actions

Artifacts

Reference Validation

Term Validation

Terms the report names something else

Terms whose name is worth a second look

Prefixes with no resolver